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ABSTRACT 
Olsen, David R.; M.S., University of Rhode Island, 
1983. Collagenase and Elastase Activities in Human and 
Murine Cancer Cells and Their Modulation by Dimethyl-
formamide. Major Professor: Dr. Clinton O. Chichester. 
The transformation from carcinoma in situ to in-
vasive carcinoma occurs when tumor cells traverse extra-
cellular matracies allowing them to move into paren-
chymal tissues. Tumor invasion may be aided by the 
secretion of collagen and elastin degrading proteases 
from tumor and tumor-associated cells. In this study 
~ the production of Type I and Type V collagen degrading 
activities and elastolytic activities by DLD-1 human 
colon carcinoma cells, B16-F10 murine melanoma cells, 
and normal human dermal fibroblasts was examined. DLD-1 
cells and normal fibroblasts produced similarly high 
levels of collagenolytic activity. DLD-1 cells also 
produced high levels of elastinolytic activity; this 
activity was found exclusively in the extracellular 
medium. DLD-1 cells and normal fibroblasts produced 
more collagen and elastin degrading activity than did 
B16-F10 melanoma cells, a cell line characterized as 
highly metastatic. The Type I and Type V collagenolytic 
ii 
activities from DLD-1 cells were separated and characterized 
using DEAE cellulose chromatography and gel filtration 
chromatography. The Type I collagenolytic activity appeared 
to be an anionic protein at pH 8.3, and two forms of the 
enzyme were detected, one with a molecular weight of 60,000 
and the other with a molecular weight of 35,000 daltons. 
The Type V collageno-ytic activity was a cationic protein 
at pH 8.3 and two forms of this activity were detected, one 
with a molecular weight of 80,000 and the second with a 
molecular weight of 54,000 daltons. 
The effect of the polar solvent, dimethylformamide 
(DMF) on the production of collagen and elastin degrading 
activities was studied using cultured DLD-1 cells. DMF 
treated cells produced significantly higher levels of 
Type I collagenolytic, Type V collagenolytic and cell-
associated elastase activities than did control cells. 
DMF treatment had no significant effect on media elastase 
levels. Treatment of DLD-1 cells with DMF elevated the 
cellular levels of protein and RNA while these same cells 
had less DNA per cell. DMF treated cells were also able 
to synthesize protein at a significantly faster rate than 
control cells. This increased rate of protein synthesis 
may account for part of the increased production of con-
nective tissue degrading enzymes seen in DMF treated cells. 
iii 
However, the effect of DMF on enzyme production was still 
present when the cells were treated with cycloheximide. 
The failure of cycloheximide to prevent the DMF induced 
increase in enzyme activity suggests that the effect of 
DMF is not entirely dependent on protein synthesis. These 
data suggest that DLD-1 hu.~an colon carcinoma cells pro-
duce at least two different collagen degrading enzymes 
and that DMF treatment may facilitate the invasive move-
ment of cancer cells during the matastatic process by 
increasing the secretion of connective tissue degrading 
enzymes. 
iv 
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INTRODUCTION 
The metastatic growth of secondary neoplasms is a 
major problem facing the oncologist because the pharma-
cological agents and medical interventions available 
cannot sufficiently control this spread. The development 
of multiple metastatic foci leads to the loss of the nor-
mal function of the invaded tissues or organs and ulti-
mately results in death. The metastatic process begins 
when tumor cells or tumor emboli disseminate from the 
primary tumor mass and invade the vasculature entering 
the circulation. The transported tumor cells arrest and 
invade the parenchymal tissue of adjacent organs, pro-
liferate and develop into secondary metastases. During 
the invasion phase of metastasis, connective tissue 
matracies are traversed. Electron micrographs of the 
invaded regions reveal the local dissolution of basement 
membranes (Birbeck and Wheatly, 1965). The mechanism of 
basement membrane destruction is uncertain. 
The extracellular matrix (ECM) is composed of several 
macromolecules including elastin, collagen, and proteo-
glycans. Elastin and collagen are resistant to degrada-
tion by most proteases. The only enzymes which can 
degrade collagen are collagenases. Enzymes which specifi-
2 
cally degrade elastin are termed elastases. 
Elastase activity is associated with several tumor 
associated cells and tumor cell lines (Mainardi et al, 
1980a; Kao et al, 1982). Collagenases are also synthesized 
by several tumor and tumor associated cells (Horwitz et al, 
1977; Mainardi et al, 1980a,b; O'Grady et al, 1982) and 
recently collagenases specific for the different types of 
collagen have been identified in the medium of certain 
tumor cell lines (Liotta et al, 1981a,b; Salo et al, 1983). 
During invasion, elastases and collagenases may be involved 
in the local destruction of basement membranes and stromal 
tissues. 
In this study Types I and V collagen degrading acti-
vities and elastase activities were measured in several 
tumor cell lines. The collagenolytic activities which 
were secreted by cultured DLD-1 human colon carcinoma 
cells were analyzed by ion exchange chromatography and gel 
filtration chromatography to determine if different 
enzymes were responsible for the degradation of Types I 
and V collagen. The results of these studies may indicate 
that destruction of ECM components by invading tumor cells 
results from the action of more than one specific degrada-
tive enzyme. 
3 
A novel attempt to control the spread of cancer has 
been the use of biological inducers as chemotherapeutic 
agents. Biological inducers are compounds which induce 
malignant cancer cells to differentiate into benign cells 
(Sachs, 1981). One such compound, dimethylformamide (DMF) 
has induced a human colon carcinama cell line, DLD-1, to 
differentiate in vitro and these treated cells have a 
reduced tumorigenic capacity in vivo (Dexter et al, 1979). 
This study will also examine the effects of DMF treatment 
on the levels of connective tissue degrading proteases in 
the DLD-1 cell line. The reduction in tumorigenicity 
seen with DMF may be paralleled by a decrease in the cell's 
ability to invade host tissues. 
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LITERATURE SURVEY 
Metastasis 
Metastasis is a multistep process in which cells 
derived from a primary tumor detach and are transported 
to a distant site where they form a secondary tumor 
(Poste and Fidler, 1980). The metastatic process is 
initiated when cells or clumps of cells dissociate from 
the primary tumor and enter blood or lymph vessels. The 
tumor cells interact with host cells as they are trans-
ported by the circulation or lymph. During this process 
some of the tumor cells may be destroyed by host defense 
mechanisms (Old et al, 1961). 
~ ~ ~ 
The circulation of tumor cells 
stops when they encounter a vessel which is too small 
to allow passage (Ziedman, 1961) or when they attach to 
vascular endothelium due to cell-cell interactions 
(Winkelhade and Nicolson, 1976). The cells may exit 
the vessel at this point, invade surrounding tissue, pro-
liferate, and develop into a secondary tumor. Alterna-
tively the arrested cells may be engulfed and destroyed 
by host macrophages and lymphocytes (Vose, 1980; Hibbs 
et al, 1977). 
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The intravenous injection of mice with syngeneic tumor 
cells is an experimental model of metastasis. This model 
is employed to study various aspects of the metastatic 
process including the organ distribution of blood borne 
tumor cells (Fidler, 1973). The growth of tumors in 
specific organs following intravenous injection of cells 
has been demonstrated with several cell lines (Kinsey, 
1960; Fidler and Nicoloson, 1976; Nicoloson and Winkel-
hade, 1975; Brunson et al, 1978). Cell types which meta-
stasize to specific organs and variants of the same parent 
line which have different capacities to form tumor nodules 
following intravenous injection exhibit difference in 
their cell surface components (Dobrassy et al, 1981; 
Brunson et al, 1978; Raz et al, 1980). Cell lines which 
~ ~ ~ ~ 
are characterized as "highly metastatic" following intra-
venous injection have greater quantities of cell surface 
sialic acid, increased levels of sialyltransferase and 
other cellular glycosidase activities (Dobrassy et al, 
1981). Sialic acid is a component of cell surface glyco-
proteins involved in cell-cell and cell-substratum 
adhesion. Others have used the intravenous injection 
model with different tumor cell lines and noted random 
growth of metastases (Proctor, 1976). Tumor nodules 
arose in organs where capillary beds were first encountered. 
Models of metastasis which employ intravenously 
injected cells are inadequate because they do not allow 
the examination of the entire metastatic process. They 
bypass the first step of metastasis when cells break off 
the primary tumor and invade the vasculature. In the 
future better models will further our understanding of 
the pathogenesis of metastasis. 
Invasion 
During invasion tumor cells traverse stromal tissue 
and blood vessels to infiltrate the parenchyma of host 
organs. The invading cells then proliferate to eventu-
6 
~ally form secondary tumors. The mechanisms involved in 
the invasive movement of tumor cells is not completely 
understood. Invasion may occur as the result of mechan-
ical pressures exerted by rapidly proliferating tumor 
cells (Eaves, 1973). The fast growing tumors create 
regions of increased pressur~ and invasion occurs at 
points where the host tissues were weakest. Infiltra-
tion of host tissues may also result from tumor cell 
products acting on stromal tissues and blood vessels 
(Fidler et al, 1978). Tumor cells synthesize and secrete 
proteases capable of degrading the host ECM (Dresden et 
al, 1972; Hashimoto et al, 1973). Areas where the matrix 
......_ 
is weakened will then be invaded by proliferating tumor 
cells. Invasion of target organs by malignant tumor 
cells in vitro can be inhibited when the incubation 
medium contains several types of protease inhibitors 
(Latner et al, 1973). 
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Stromal tissues and blood vessels are partially 
composed of the structural proteins collagen and elastin, 
these proteins are degraded by specific enzymes called 
collagenases and elastases. Analysis of the media from 
cultured tumor cells has confirmed the presence of colla-
genase and elastase activities (Liotta et al, 1979; Kao 
et al, 1982; O'Grady et al, 1982). These enzymes may aid 
invading tumor cells but this has not been proven. In-
vasion most likely results from a combination of mechan-
ical forces exerted by proliferating tumor cells and de-
gradative enzymes secreted by tumor and tumor associated 
cells. 
Modulation of Tumor Cell Growth 
Tumor cells established in vitro are less differ-
entiated than the normal cell-type from which they 
originated (Market, 1968). The decreased extent of 
differentiation characteristic of malignant cells is 
8 
thought to result from an imbalance between the number of 
genes which express and suppress normal growth and dif-
ferentiation (Rabinowitz and Sachs, 1970). In vitro induc-
tion of differentiation of tumor cells has been achieved 
using several compounds. Dimethylsulfoxide has induced 
erythroleukemia cells to differentiate resulting in their 
synthesis of hemoglobin (Friend et al, 1971). Cyclic 
adenosine 3~, 5~ monophosphate and dibutyryl cyclic 
adenosine monophosphate stimulated cellular differentia-
tion leading to increased melanin synthesis, cellular 
enlargement and increased dendrite formation in B16 mel-
anoma cells (Kreider et al, 1973). Hexamethylene bisace-
tamide induced morphological changes (cell elongation) and 
maturational changes in a malignant mesenchymal cell line 
(Rabson et al, 1977). The agent caused a shift from the 
synthesis of Type III collagen to the synthesis of Type I 
collagen. Dimethylformamide (DMF) has induced morpholo-
gical changes and reduced the tumorigenicity of rhabdo-
myosarcoma cells (Dexter, 1977). DMF has also induced 
the loss of tumorigenicity and clonogenicity of the human 
colon carcinoma cell line DLD-1 (Dexter et al, 1979). 
DLD-1 cells treated in vitro with DMF have exhibited a 
decreased expression of tumor associated antigens and an 
increase in the amount of normal colonic surface antigen 
(Hager et al, 1980). DMF alters several in vitro growth 
..... 
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characteristics of DLD-1 cells causing their doubling time 
to increase and their saturation density to decrease 
(Dexter et al, 1979). These data suggest that DMF has 
induced a malignant cell type to differentiate and mature 
into a cell-type with benign phenotypes. The effect of 
biological inducers such as DMF on the invasive capacity 
of tumor cells has not been studied, these experiments 
may provide information on the modulation of the meta-
static potential of tumor cells. 
Collagen Heterogenity 
Collagens are a group of triple-helical, inflexible, 
rod-shaped proteins found in mammalian connective tissues . 
Collagens have a 20% imino acid (proline and hydroxypro-
line) content, a 30% glycine content and are glycosylated 
(Burgeson, 1982). The precursor subunits of collagen, 
procollagen alpha (pro°') chains undergo several post-
transla t ional modifications. The first modification is 
the enzymatic hydroxylation of specific prolyl and lysyl 
residues (Prockop and Juva, 1965). Carbohydrate moieties 
are then added to some of the hydroxylysyl residues by 
galactosyl and glucosyltransferases (Spiro and Spiro, 1971). 
These events are followed by intra- and interchain di-
sulfide bond fomration and packaging of proo{ chains into 
10 
a triple helix (Ditto and Prockop, 1973). Triple helical 
procollagen molecules are packaged into secretory gran-
ules in the Golgi complex and are ready for export (Wein-
stock and Leblond, 1974). Extracellularly procollagen 
molecules are modified by procollagen peptidases (Lapiere 
et al, 1971). These enzymes cleave off non-helical pep-
tides from the NH 2 and COOH terminal ends of procollagen 
to form collagen. 
In the extracellular matrix collagen fibers aggre-
gate to form orderly fibrils via parallel lengthwise 
interactions (Prockop et al, 1979). The fibrils are 
stabilized by intra- and intermolecular covalent cross-
links formed following oxidative deamination of lysine 
and hydroxylysine residues by the enzyme lysyl oxidase 
(Pinell and Martin, 1968). Crosslinks are formed when 
enzymatically produced aldehydes react with lysine or 
hydroxylysine residues (Siegel and Martin, 1970). Cross-
link formation increases the collagen fibrils resistance 
to degradation by collagenase (Vater et al, 1979). 
Presently five major collagen types and several minor 
collagenous proteins have been identified (Burgeson, 1982). 
The major collagens, designated Types I, II, III, IV, and 
V, differ in subunit composition, carbohydrate content, 
11 
tissue distribution and arrangement in the extracellular 
matrix (Bornstein and Sage, 1980). The minor collagenous 
proteins which have been partially characterized include 
the E and F chains of human hyaline cartilage (Burgeson 
and Hollister, 1979), the HMW and LMW collagenous frag-
ments of chick hyaline cartilage (Reese et al, 1979), EC 
collagen synthesized by cultured endothelial cells (Sage 
et al, 1980) and a collagenous fragment isolated from 
placental tissue (Furuto and Miller, 1980). 
Types I, II, and III collagen, collectively called 
the interstitial collagens, are the major structural com-
ponents of connective tissues. The interstitial collagens 
~are composed of three subunit polypeptide chains called 
alpha (q ) chains. Alpha chains from Types I, I I, and I I I 
collagen differ in amino acid composition and size, 
additionally the three~ chains of Type I collagen are 
not similar. Type I collagen is composed of two different 
subunits designatedo< l(I) 2 o\2(I). Type II collagen is 
composed of three idential a'. chains represented by the 
formulao< l(II) 3 • Type III collagen has a molecular 
configuration of P'( 1 (I I I) 3 (Bornstein and Sage, 198 0). 
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The basement membrane collagens Types IV and V make up 
a minor portion of the total collagenous fraction of the 
extracellular matrix. Type IV collagen has been localized 
to the basement membranes of most tissues (Bornstein and 
Sage, 1980). Type IV collagen is composed of three o{ chains 
which are biochemically distinct from those of the inter-
stitial collagens. Two different O'\ chains have been identified 
and are designated o( l(IV) and~ 2(IV) (Sage and Bornstein, 
1979). Type IV collagen o( chains contain more 4-hydroxypro-
line than 3-hydroxyproline which is present in interstitial 
collagens. They contain more carbohydrate residues than 
interstitial collagens and these chains are stabilized by 
disulfide bonds (Sage et al, 1979). The IV collagen cl; 
chains are wound into a triple helix and form fibers which 
are different from other collagenous fibers. Type IV colla-
gen fibers are composed of four distinct regions; at one end 
there is a non-collagenous globular peptide called NCl, the 
second region is the major triple helical domain which con-
tains several regions where the triple helix is interrupted. 
The third region is another non-collagenous domain called 
NC2, and the other end of the fiber is a collagenous peptide 
called the 7S domain (Timpl et al, 1981; Schuppan et al, 
1980; Glanville and Rauter, 1981). Type IV collagen fibers 
do not appear to be processed by procollagen peptidases 
13 
(Dehm and Kefalides, 1978). These fibers exhibit a speci-
fic orientation in basement membranes. The globular 
heads (NCl) of two fibers are connected in a non-covalent 
manner while the 78 domains of four fibers from aggre-
gates (Timpl et al, 1981). The association of four 78 
domains yields a structure termed 78 collagen (Risteli 
et al, 1980). 7S collagen is more stable than other 
collagenous proteins due to extensive disulfide bonding 
between subunits and it is partially resistant to diges-
tion by bacterial collagenase. 
Type V collagen, discovered in 1976 by two groups of 
investigators (Chung et al, 1976; Burgeson et al, 1976) 
represents approximately 5% of the total collagenous 
fraction of tissues. Immunofluorenscence has localized 
Type V collagen in basement membranes and on the peri-
cellular surface of cells (Madri and Furthmayr, 1980; Gay 
et al, 1981). This type of collagen has been isolated 
from several tissues including vasculature, skin, synovium, 
gingiva, liver, tendon, placenta, bone, lung, and muscle 
(Bornstein and Sage, 1980). The exact function of Type V 
collagen is not known, it may be involved in cell migra-
tion (Stenn et al, 1979) and may play a role in stabilizing 
cytoskeletal architecture. 
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The physical properties of Type V collagen are simi-
lar to the other collegens. Four different Type V colla-
gen o\ chains have been isolated and are designated 
o( l(V),o\ 2(V), P°\3(V), and d\4(V) (Sage and Bornstein, 
1979; Fessler et al, 1983). Presently, the exact molecular 
configuration of Type V collagen is not established. Most 
preparations are composed of two~ l(V) chains and one 
~ 2(V) chain, the ~3(V) orC"\4(V) chains may be present 
depending on the tissue source (Rhodes and Miller, 1978; 
Bentz et al, 1978; Sage and Bornstein, 1979; Fessler et al, 
1983). Type V collagen is glycosylated like the other 
collagens, it's carbohydrate content is intermediate 
between the interstitial and basement membran e collagens 
(Burgeson et al, 1976). It is secreted into the extra-
--.. --
cellular matrix in a procollagen form and undergoes limited 
proteolysis by procollagen peptidases (Kumamoto and 
Fessler, 1981). The globular extension peptides which 
remain intact are larger than those of Types I, II, and 
III collagen but smaller than those of Type IV collagen. 
The triple helical region of Type V collagen is also larger 
than the triple helicies of Types I, II, and III collagen 
(Burgeson et al, 1976). The configuration of Type V coJla-
gen fibers in the extracellular matrix is not firmly 
established. The fibers appear to interact forming 
parallel longitudinal arrays of fibrils similar to those 
formed by interstital collagens (Bentz et al, 1978). 
The thermal stability of the Type V collagen triple 
helix appears to be similar to the helicies of other 
collagens, all have mid-point melting temperatures (TM) 
of 37°C (Rhodes and Miller, 1978). The Type V collagen 
15 
melting curve shows a slight inflection at 33°C-35°C which 
suggests the existence of two distinct molecules, one 
being less heat stable than other collagenous molecules. 
This unstable species may allow catabolism of the mole-
cule by proteases which do not degrade triple helical 
collagen but can degrade denatured collagen. Type V 
collagen is degraded by thrombin, trypsin, chymotrypsin 
and elastase at temperatures above 34°C (Sage et al, 1981). 
At these temperatures the triple helix of Type V collagen 
begins to denature making the molecule more susceptible to 
degradation. 
Mammaliam Collagenase 
The catabolism of collagen is initiated by the enzyme 
collagenase. Collagenases are a family of enzymes which 
play an important role in tissue remodeling (Mainardi et 
al, 1980a) and certain pathological states such as 
rheumatoid arthritis (Evanson et al, 1968). They are 
......_ 
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the only enzymes capable of initiating the breakdown of 
mature triple helical collagen (Gross et al, 1974). Collagen-
ases act by making one break in all threeo( chains in the 
triple helical region of the molecule. The cleavage site 
in Type I collagen has been localized to glycine residue 
778 and isoleucine residue 779 which occur three quarters 
of the distance down the length of the<?\ chains from the 
amino terminal end (Gross et al, 1974). Two digestion 
fragments are formed as a result of enzymatic cleavage, 
the TCA and TCB fragments. The TCA fragment represents 
75% of the o'\ chain and the TCB fragment is 25%. The pro-
duction of specific reaction products at neutral pH and 
temperature which supports a triple helical conformation 
of the substrate is one method of identifying a protease 
as a true collagenase (Harris and Vater, 1982). These 
specific reaction products were first identified by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) following incubation of Type I collagen with 
tadpole tailfin collagenase (Gross and Nagai, 1965). 
Following the initial cleavage by collagenase the 
collagen triple helix denatures under physiological con-
ditions, the TCA and TCB fragments are not thermally 
stable at temperatures above 34°C (Sakai and Gross, 1967). 
The denatured molecule is now susceptible to degradation 
17 
by non-specific proteinases (Harper, 1980). Denatured 
collagen fragments are degraded into smaller peptides by 
enzymes called gelatinases (Vaes et al, 1978). Collagenase 
isolated from fibroblasts can degrade denatured as well as 
native collagen; however, the rate of proteolysis of native 
substrate is faster (Welgus et al, 1982). 
The study of collagen catabolism has led to the dis-
covery of substrate specific collagenases. Collagen 
Types I, II, and III are degraded by classic or inter-
stitial collagenase (Harper, 1980). This enzyme does not 
degrade Types IV and V collagen (Sage et al, 1979; Liotta 
et al, 1981a; Woolley et al, 1978). Interstitial colla-
genases have been isolated from several cell types in-
cluding fibroblasts (Bauer et al, 1975), macrophages 
(Mainardi et al, 1980a), polymorphonuclear leukocytes 
(PMN) (Horwitz, 1977), eosinophils (Hibbs et al, 1982), 
bone cells (Puzas and Brand, 1979), rheumatoid synovial 
cells (Woolley et al 1975a) and several tumor cell lines 
(Wolf et al, 1982; O'Grady et al, 1982; Liotta et al, 
1979). All collagenases studied share several properties 
including: (1) a pH optimum in the range of neutrality; 
(2) require Ca2+ for maximal activity; (3) are inhibited 
by ethylenediamine tetracetic acid (EDTA), a metal ion 
~ 
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chelator and thus are characterized as metalloproteinases; 
(4) produce TCA and TCB reaction products under non-
denaturing conditions; and (5) they are synthesized in a 
latent form requiring activation for maximal activity. 
Collagenases which degrade interstitial collagen have 
been purified from several sources using a variety of 
techniques. A range of molecular weights from 30,000 to 
150,000 daltons have been reported for the different 
purified collagenases (Nagai, 1973). Collagenase in tissue 
culture medium or tumor homogenates is usually purified by 
ammonium sulfate fractionation followed by ion exchange 
chromatography and/or affinity chromatography. These pro-
cedures are followed by gel filtration chromatography and 
molecular weight determination on SDS-PAGE. 
Collagenase isolated from the medium of cultured 
human skin fibroblasts is the best characterized form of 
the enzyme. Fibroblast collagenase appears to have both 
cationic and anionic regions, it bi~ds to anionic resins 
(Woolley et al, 1973), and cationic resins (Stricklin et 
al, 1977) at similar pH and salt concentrations. Fibro-
blasts secrete collagenase in a latent procollagenase form 
(Bauer et al, 1975), two different procollagenases with 
molecular weights of 60,000 and 55,000 daltons have been 
identified (Stricklin et al, 1977). Procollagenase does 
not bind to collagen substrates, upon activation the 
enzyme binds tightly to its substrate (Stricklin et al, 
1978). The two forms of procollagenase can be activated 
by limited tryptic digestion to give two active species 
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of enzyme with molecular weights of 50,000 and 45,000 
daltons (Stricklin et al, 1977). Fibroblast procollagenase 
can also be activated by organomercurial compounds, this 
reaction proceeds without an initial decrease in enzyme 
molecular weight (Stricklin et al, 1983). Lower molecular 
weight species are formed, however, their production is 
not coincident with the increase in enzyme activity 
(Stricklin et al, 1983). Autocatalytic cleavage is re-
~sponsible for the eventual decrease in enzyme molecular 
weight (Stricklin et al, 1977). 
Collagenases which degrade interstitial collagen have 
been purified to homogeneity from several sources. Colla-
genase from rabbit v2 ascites cell carcinomas and Walker 
256 carcinoma cells have been purified to homogeneity and 
molecular weights (MW) of 34,000 and 42,000 daltons, 
respectively, were reported (McCroskery et al, 1975; Wolf 
and Wirl, 1982). Other collagenases which have been 
isolated in pure form include human rheumatoid colla-
genese MW 33,000 daltons (Woolley et al, 1975a), porcine 
--. 
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synovial collagenase MW 44,000 daltons (Cawston and Tyler, 
1979), neutrophil collagenase MW 70,000 daltons (Christ-
ner et al, 1982), and guinea pig skin collagenases MW 40, 000 
and 130,000 daltons (Huang and Abramson, 1975). Fiedler-
Nagy et al (1977) have isolated collagenase from human 
fibroblast cultures. They reported a series of peaks of 
enzymatic activity following gel filtration chromato-
graphy which corresponded to MW of 40,000 to 150,000 
daltons. They found that the enzyme was present in a 
tightly bound complex with a hydroxyproline containing 
peptide, most likely a fragment of collagen. Complexes 
of collagenase and different sized collagenous fragments 
were responsible for the numerous peaks of enzyme activity. 
These types of complexes may also account for the dif-
ferences in MW values reported for different purified 
collagenases. 
Collagenases which specifically degrade Type IV 
collagen have been isolated from human leukocytes (Ditto 
et al, 1980) and from the medium of a cultured metastatic 
murine sarcoma cell line (Liotta et al, 1979). Type IV 
collagenase from sarcoma cells was later purified (Salo 
et al, 1983). The isolated activity had a MW of 160,000 
daltons, if Triton X-100 was added to the preparation and 
rechromatographed its MW decreased to 70,000 daltons. 
This indicated the enzyme has hydrophobic properties and 
the large molecular weight form may be an aggregate of 
enzyme molecules. SDS-PAGE further separated the activ-
ity into two distinct components with MW of 68,000 and 
62,000 daltons. The Type IV collagenase was secreted in 
a latent form, required Ca2+ for activity and produced 
specific reaction products. 
The degradation of Type IV collagen by PMN elastase 
has been reported (Mainardi et al, 1980b). PMN's also 
contain a collagenase which degrades interstitial colla-
gens (Horwitz et al, 1977). The PMN Type IV collagenase 
described by Uitto et al (1980) is different from the 
interstitial collagenase, however, it may be an elas-
tase-like protease similar to that reported by Mainardi 
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et al (1980b). It has several properties which are 
characteristic of elastases including inhibition by phenyl-
methylsulfonyl floride (PMSF), an inhibitor specific for 
serine proteases (Fahrney and Gold, 1963). 
Type V collagen specific degrading activities have 
been detected in the medium of cultured normal and mali-
gnant macrophages (Mainardi et al, 1980a; Liotta et al, 
198lb). Mainardi separated normal macrophage Type I and 
Type V collagenases using DEAE cellulose chromatography. 
-..... 
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The Type V collagenase was characterized as a neutral pro-
tease inhibited by EDTA but not PMSF. Liotta et al (1981b) 
characterized a Type V collagen degrading activity synthe-
sized by malignant macrophages. This activity was secreted 
in a latent form, was inhibited by EDTA but not PMSF, pro-
duced specific reaction products and had a MW of 80,000 
daltons as determined by gel filtration chromatography. 
Regulation of Collagenase Activity 
Collagenases are secreted by most cells in a latent 
form, requiring activation for maximal activit y (Bauer et 
al, 1975). The exact nature of latent collagenases has 
not been established. The enzyme may be secreted as an 
enzyme-inhibitor complex (Sellers et al, 1977 ) or in 
zymogen form (Stricklin et al, 1977). Activation of 
latent collagenases usually proceeds with a d ecrease in 
molecular weight of 10,000 to 20,000 daltons (Stricklin 
et al, 1977; Sellers et al, 1977; Wolf and Wirl, 1982). 
Limited proteolysis of latent collagenase results in 
increased enzymatic activity. In vitro several proteases 
catalyze this activation process, included are trypsin 
(Bauer et al, 1975), plasmin (Vaes et al, 1975), mast 
cell proteinase (Birkedal-Hansen et al, 1976), endogenous 
serine protease (Woessner, 1977), tadpole proteinase 
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(Harper et al, 1971), lysozomal protease (Eeckhout and 
Vaes, 1977) and metalloproteinases (Horwitz et al, 1976). 
Collagenase can be activated in vitro by several non-
proteolytic mechanisms. Incubation of latent enzyme with 
chaotropic ions such as I and SCN-, organomercurial com-
pounds (Stricklin et al, 1983) and disulfide containing 
compounds (McCartney et al, 1980) all produce a more active 
species of collagenase. These compounds act by dissociating 
enzyme-inhibitor complexes or by disrupting the configura-
tion of the native zymogen enzyme (Stricklin et al, 1983). 
These processes are followed by autocatalytic intramole-
cular activation, and the active enzyme formed is of lower 
molecular weight (Bauer et al, 1975; Stricklin et al, 1977). 
The production of collagenases is regulated by the 
capacity of the cell to synthesize the protein (Valle and 
Bauer, 1977) and by the degree to which the cell is stimu-
lated by surrounding cells. Johnson-Muller et al (1978) 
showed that normal epithelial cells stimulate the release 
of collagenase from stromal cells via the action of a 
soluble factor. Macrophages and T-lymphocytes also 
secrete a soluble factor which stimulates release of 
collagenase from synovial cells (Dayer et al, 1979). 
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Secretion of collagenases by fibroblasts is increased when 
the fibroblasts are cocultured with B-16 melanoma and A-10 
adenocarcinoma cells, two epithelial-like tumor cell lines 
(Biswas, 1982). Rat mammary adenocarcinoma cells, also an 
epitelial-like tumor cell secrete plasminogen activator CPA). 
PA catalyzes the formation of plasmin, this protease can 
stimulate collagenase activity in vivo by activating latent 
collagenases present in stromal tissues ( 0' Grad_y et al, 1980). 
Cell-cell interactions may be important during invasion, such 
interactions can result in increased levels of collagen de-
grading enzymes in the extracellular matrix. These enzymes 
may facilitate the breakdown of connective tissue barriers 
encountered by invading tumor cells. 
Collagenase Inhibitors 
Collagenases are inhibited by both tissue specific 
inhibitors and by several components of serum. Normal 
serum has been fractionated by isoelectric focusing and 
three inhibitory zones have been identified according to 
their electrophoretic mobility. They are the'7( , ~ , 
and 0 zones (Broth et al, 1981). The major inhibitory 
component of serum, found in the ~-zone is o( 2 macro-
globulin. c;;:{ 2 macroglobulin is a non-specific inhibitor of 
most endopeptidases (Seifter et al, 1970). Also present 
in this fraction are antithrombim III and ~l anti trypsin, 
the latter has only minor collagenase inhibitory 
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capacity (Woolley et al, 1975b). The second fraction of 
serum, the ~ -zone contains a low molecular weight protein 
named ,f> 1- anticollagenase which specifically inhibits 
collagenase but not other proteases (Woolley et al, 1976). 
The ~ electrophoretic zone of serum contains a cationic 
protein which inhibits collagenase. This protein may be 
the Clq component of complement which has a collagen-like 
structure. It inhibits collagenase by acting as a com-
petitive substrate (Nagai et al, 1978). 
Several tissue specific collagenase inhibitors have 
been identified. Keuttner et al (1976) characterized a 
low molecular weight (11,000 daltons) cationic protein 
from bovine aorta and cartilage which inhibit e d colla-
-.... 
genases under physiological conditions. Two groups have 
isolated and characterized a 28,000 dalton protein from 
amniotic fluid which inhibits collagenolytic activity 
(Murphy et al, 1981a; Aggeler et al, 1981). Additional 
tissue specific collagenase inhibitors have been isolated 
from human synovium (Murphy et al, 198lb), rabbit bone 
cells in culture (Cawston et al, 1981), cultured human 
skin fibroblasts (Welgus et al, 1979), and porcine gingival 
explants (Pettigrew et al, 1981). 
...__ 
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Elastin 
Elastin is a structural protein found in the extra-
cellular matracies of several tissues including lung, skin, 
blood vessels, cartilage, and breast (Werb et al, 1982). 
Elastin provides these tissues with tensile strength and 
elasticity (Anwar et al, 1977). Alterations in elastin 
metabolism are associated with several disease states 
(Sandberg et al, 1981). Desmoplasia, the excessive deposi-
tion of stromal connective tissue is often associated with 
the growth of invasive breast carcinomas (Barsky et al, 
1982). Accumulation of newly synthesized elastin is a 
common feature associated with the desmoplastic response 
(Lundmark, 1972) . 
The primary structure of elastin is unique in that it 
contains large quantities of non-polar amino acids (Keeley 
et al, 1974). Tropoelastin, the subunit of mature elastin 
contains 11 repeating sequences of the pentapeptide val-pro-
gly-val-gly, a second hexapeptide pro-gly-val-gly-val-ala 
found in a trypsin-sensitive region of tropoelastin repeats 
itself 6 times (Foster et al, 1973). Tropoelastin also has 
a high lysine content, these residues are present in pairs 
separated by 1 to 3 alanine residues and preceded by 1 to 8 
alanine residues (Sandberg et al, 1972). Tropoelastin 
subunits are crosslinked to form elastin following the 
oxidative deamination of specific lysine residues by the 
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enzyme lysyl oxidase (Pinell and Martin, 1968). The 
enzymatically formed reactive aldehyde groups of adjacent 
subunits spontaneously react to form covalent bonds. The 
crosslinking residues desmosine and isodesmosine are 
formed when three deaminated lysine residues and one 
epsilon amino group of a fourth lysine from tropoelastin 
monomers are joined (Lent et al, 1969). Crosslinks 
stabilize the protein and make it resistant to proteo-
lysis (Stone et al, 1982). Elastin fibers in the extra-
cellular matrix consist of two components: (1) a micro-
~f ibrillar component which is very susceptible to degrada-
tion and (2) an amorphous component which is resistant to 
proteolysis (Werb et al, 1982). 
Elastase 
Mature elastin is degraded by several enzymes known 
as elastases. Elastolytic activity has been detected in 
the ~-cells of the pancreas (Marshall et al, 1969), 
PMN's (Ohlsson and Olsson, 1974), macrophages (Banda and 
Werb, 1981), platelets (Hornebeck et al, 1980), smooth 
muscle cells and fibroblasts (Boudillon et al, 1980), 
-..... 
human breast carcinoma cells (Kao et al, 1982) and meta-
static human tumor cells (Jones and DeClerck, 1980). 
These elastolytic activities cleave the elastin molecule 
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in different sites, are inhibited by different compounds, 
and have different cellular locations. Elastin has 
multiple cleavage sites and is degraded to several low 
molecular weight peptides by elastases (Werb et al, 1982). 
The cleavage site for pancreatic, macrophage, and PMN 
elastases have been identified. Pancreatic elastase 
cleaves peptide bonds in elastin which are carboxyl to 
glycine, valine and alanine residues (Barrett et al, 1980). 
This elastase is inhibited by PMSF and classified as a 
serine protease (Fahrney and Gold, 1963). Macrophage 
elastase only cleaves peptide bonds on the amino side of 
leucine residues (Banda and Werb, 1981). Macrophage 
elastase is characterized as a metal-dependent proteinase, 
its activity is blocked by EDTA (White et al, 1980). 
Elastase from PMN's cleaves elastin at sites which are 
carboxyl to alanine and valine residues (Barrett et al, 
1980). This enzyme is inhibited by PMSF and is a serine 
protease. Fibroblast elastase has been characterized as 
a metal-dependent protease (Bourdillon et al, 1980). The 
elastolytic activity associated with cultured human breast 
carcinoma cells is inhibited by both EDTA and PMSF, these 
cells may contain more than one protease which degrades 
elastin substrates (Kao et al, 1982). 
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Pancreatic elastase is secreted from the -.E3-cells in 
an inactive form and is activated by trypsin in the 
intestine (Barrett et al, 1980). PMN elastase has been 
localized inside the cell in azurophil granules (Werb et 
al, 1982). Elastase from macrophages and human breast 
carcinoma cells is found in the medium when these cells 
are maintained in culture (Banda and Werb, 1981; Kao et al, 
1982). The elastolytic activity of metastatic human tumor 
cells was not detected in the medium or inside the cells 
and was present only when the cells were attached to a 
suitable substrate (Jones and DeClerk, 1980). Smooth 
---
muscle cell and fibroblast elastases are not secreted into 
the growth medium but these activities can be extracted fran 
cell sonicates using Triton X-100, suggesting they are mem-
brane bound (Hornebeck et al, 1980). 
Elastase Inhibitors 
The activity of elastases are limited by the presence 
of several natural inhibitors (Werb et al, 1982). The two 
major elastase inhibitors are found in the serum, they are 
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cA 1 antitrypsin and °' 2 macroglobulin (Ohlsson and Olsson, 
1974). Pancreatic and PMN elastases are more susceptible 
to inhibition by c)\ 1 antitrypsin than ~ 2 macroglobulin. 
Macrophage elastase is primarily inhibited by c::\ 2 macro-
globulin. Macrophage elastase also inactivates ~ 1 anti-
trypsin by degrading it, freeing other bound inactivated 
elastases (Banda et al, 1980). Imbalances in the ratio of 
elastases to inhibitors where elastases arein excess are 
thought to be involved in disease states such as chronic 
obstructive pulmonary disease (Eriksson, 1979), rheumatoid 
arthritis (Cox and Huber, 1976), and emphysema (Stone et 
al, 1982). 
EXPERIMENTAL 
Materials 
All reagents used in this study were of analytical 
grade. Reagents used included [ 3H]-sodium borohydride, 
specific activity 100 mCi/mmol, [2-3H]-glycine, specific 
activity 44 Ci/mmol, [1-14c]-acetic anhydride, specific 
activity 10 mCi/mmol and Atomlight liquid scintilation 
fluid, purchased from New England Nuclear Corporation. 
Trypsin, 2X crystallized was purchased from Worthington 
Biochemical Corporation. Soybean trypsin inhibitor type 
II-S, pepsin, 2X crystallized and bacterial collagenase 
Type VII were from Sigma Chemical Company. Acrylamide, 
N', N'-methylene bisacrylamide, sodium dodecyl sulfate, 
N, N, N, N tetramethylenediamine, ammonium preoxysulfate 
and CoomassieBrilliant Blue were obtained from Eastman 
Kodak. Ultrogel AcA44 was purchased from LKB and 
diethylaminoethyl cellulose (DE-52) was from Whatman. 
All tissue culture reagents were obtained from Grand 
Island Biological Company. 
Cell Culture 
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The cell lines used in this study were obtained from 
the Roger Williams General Hospital Cancer Center and 
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included: DLD-1 a human colon carcinoma (Dexter et al, 1979), 
Bl6-Fl0 a murine melanoma (Fidler, 1973), and normal human 
dermal fibroblasts. DLD-1 cells were grown in RPMI 1640 
medium supplemented with 10/. heat inactivated fetal calf 
serum (FCS), 100 U penicillin/ml, 100 µg streptomycin/ml, 
2.5 µg Fungizone/ml, 20 µg gentamycin/ml, 60 µg Tylocine/ml 
and buffered with 0.075% NaHC03 , 10 µM Hepes and 10 µM Tri-
cine. Fibroblasts were grown in Dulbecco's Modified Eagle 
(DME) medium supple~ented with 10% FCS, 3.5 mg glucose/ml, 
100 U pencillin/ml and 100 µg streptomycin/ml. B16-F10 
cells were grown in Minimum Essential Medium supplemented 
with 10% FCS, 100 U pencillin/ml, 100 µg streptomycin/ml, 
2.5 µg Fungizone/ml, 200 µg gentamycin/ml, 20 mM gultamine, 
~ 1 mM non-essential amino acids, 1 mM sodium pyruvate and 
buttered with 0.1% NaHC03 and 2 µM Hepes. 
Cells were maintained in a humidified environment at 
37°C containing 5% co2 and 95% air in 100 x 20 mm tissue 
culture dishes (Falcon 3003). Confluent monolayers were 
subcultured by removing the medium by suction, washing the 
cell layer with isotonic phosphate buffered saline (PBS) pH 
7.0 and incubating the cultures in PBS which contained 0.25% 
trypsin, 0.2 mg glucose/ml and 0.2 mg EDTA/ml. Detached 
cells were centrifuged for 5 minutes at 500 Xg and 
resuspended in fresh medium. Each dish of cells was re-
plated into four 100 x 20 mm tissue culture dishes. 
Preparation of Culture Media for Enzyme Assays 
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Media from cell cultures were assayed for Types I and 
V collagen degrading activities and elastase activity. The 
secreted enzymes were precipitated and concentrated by ammon-
ium sulfate fractionation using the method of Liotta et al 
(1981). The medium of late log phase cultures was decanted 
and the cell layers were washed three times with PBS. Fresh 
serum-free media (10 mls/100 x 20 mm plate) was added and 
cultures were incubated for 24 hours. The medium from three 
100 x 20 mm plates was pooled and centrifuged for 5 minutes 
at 900 Xg to remove cells and debris. Medium proteins were 
precipiated by addition of crystalline ammonium sulfate to 
60% of saturation and centrigured for 60 minutes at 27,000 
Xg at 4°C. Precipitates were resuspended in 2 ml of 0.05M 
Tris-HCl pH 7.5 containing O.OlM CaC12 and dialyzed against 
10 liters of this buffer for at least 16 hours at 4°C. Ali-
quots of the dialysate were activated by incubation with 
trypsin (10 ~g/ml) at a 4:1 dialysate to trypsin ratio for 
5 minutes at 37°C. The reaction was halted by addition of 
a five molar excess of soybean trypsin inhibitor, samples 
were cooled to 4°C, and then assayed for enzymatic activity. 
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Preparation of Cells for Elastase, Protein and DNA Assays 
Cell layers were harvested by incubation with PBS con-
taining 1 mM EDTA at 37°C. Detached cells were collected 
and washed three times with 0.05M Tris-HCl pH 7.5 containing 
0.9/. NaCl and 0.01 M CaC1 2 . The cells were resuspended in 
1 ml of idalysis buffer which contained 0.1/. Triton X-100 
and sonicated three times for 10 seconds at 50 watts. Ali-
quots of the sonicate were used for elastase assays and 
determination of protein and DNA content. 
Dirnethylformamide (DMF) Treatment 
DMF was added to RPMI culture medium to give a final 
concentration of 0.8/. (V/V). DLD-1 colon carcinama cells 
were grown in this media and only cells which had been sub-
cultured 3-5 times were used. This dose of DMF is not 
toxic to this cell line and the cells displayed the mor-
phologic changes described by Dexter et al (1979) after 
3 passages. 
Measurement of Protein Synthesis 
The effect of DMF treatment on the capacity of DLD-1 
colon carcinoma cells to synthesize and secrete protein was 
--. 
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studied by measuring the incorporation of 3H-glycine into 
trichloracetic acid (TCA) precipitable cellular and media 
protein. Control and DMF treated DLD-1 cells were plated 
into 100 x 20 mm culture dishes at a density of 1 x 106 
cells/plate in 10 ml of media. The experiments were per-
formed when the cultures were in the late log phase of 
growth. The medium was removed and replaced with 10 ml 
of fresh medium supplemented with 1% FCS and 5 µCi/ml 
2- 3H-glycine. Incorporation of 3H-glycine into protein 
was measured after 3 and 6 hours of incubation. At these 
times the media were collected and the cells were immediately 
washed 3 times with PBS containing 5 µg cycloheximide/ml. 
The cells were detached with 0.25% trypsin-PBS, counted and 
sonicated in PBS containing 5 µg cycloheximide/ml 3 times 
for 10 seconds at 50 watts. Medium and cell proteins were 
precipiated by addition of ice cold TCA to a final concen-
tration of 10%. Protein precipitates were washed three 
times with 5 ml of ice cold 10% TCA then hydrolyzed in 1 ml 
of Digestol (Yorktown Research) for 3 hours at 60°C. The 
hydrosylates were mixed with 10 ml of Econofluor liquid 
scintilation fluid and the radioactivity determined. Ali-
quots of the cell sonicates were removed prior to precipi-
tation and used for protein and DNA determinations. 
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Protein Determination 
All cell and medium enzyme values in this study were 
normalized using total intracellular protein values. Pro-
tein content was determined by the method of Lowry et al 
(1951); bovine serum albumin was used as a standard. An 
aliquot of 0.01 ml of the cell sonicate was used in each 
determination. 
DNA Determination 
The DNA content of cell mornoayers was determined using 
the fluorometric assay of Prasad et al (1972). Bovine 
thymus DNA was used as a standard. In a typical assay 0.1 
ml of cell sonicate was diluted with 0.4 mls of PBS. 
Ethidium bromide (10 µg) was added to each assay, this com-
pound intercalates nucleic acids making them fluorscent. 
Any RNA present was digested by addition of 200 µg of 
ribonuclease. Fluorescence was measured at an excitation 
wavelength of 360 nm and an emission wavelength of 590 nm. 
The fluorescence observed before addition of ribonuclease 
minus that observed after its addition was used to calcu-
late the a.mount of DNA present. The decrease in fluore-
scence following ribonuclease treatment represents the 
RNA content. 
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Purification of Collagens 
Type I collagen previously purified in this laboratory 
by the method of Fuji and Kuhn (1975) was labeled with 14c-
acetic anhydride and used as a Type I collagenase substrate. 
Type V collagen was purified by the method of Rhodes and 
Miller (1978). Human placentas were collected and stored 
forzen at -20°C until sufficient quantities were accumulated. 
Placentas were thawed, the amnionic membranes were removed 
and used in subsequent steps. All of the following procedures 
were carried out at 4°C. The membranes were extracted for 2 
days in 0.9% NaCl and for 2 days in 0.5 M acetic acid, both 
extractions were performed in the presence of protease in-
~ hi bi tors. The purification procedure is outlined in Figure 1. 
Amnions were minced and centrfuged and the wet weight was 
determined. The minced tissues were suspended in 0.5 M ace-
tic acid at a ratio of 20 grams wet tissue/100 ml of acetic 
acid. Pepsin, 1500 units/ml, was added to the suspension, 
stirred for 24 hours then centrifuged for 45 minutes at 
30,000 Xg. The supernatant fluid was collected and crystal-
line NaCl was added to a final concentration of 0.8 M. The 
solution was stirred for 24 hours, then centrifuged for 45 
minutes at 30,000 Xg, and the pellet was discarded. The 
supernatant NaCl concentration was increased to 1.2 M by 
the addition of crystalline NaCl, and the solution was 
CLARIFIED PEPSIN DIGEST 
Add NaCl to O.BM 
Precipitate SUPERNATE 
Add NaCl to l.2M 
PRECIPITATE 
Dissolve in 1. Oili NaCl pH 7. 4 
Supernate 
Add NaCl 4.5M 
PRECIPITATE Supernate 
Dissolve in O.lM Acetic Acid 
Add NaCl to 1.2M 
Supernate 
Dissolve in O~lM NaCl pH 7.4 
Dialyze vs. 0.02M NaCl 
PRECIPITATE 
TYPE V COLLAGEN 
2.0M Urea pH 8.6 
Supernate 
Figure 1: DIAGRAM OF THE PURIFICATION PaOCEDURE USED TO 
ISOLATE TYPE V COLLAGEN. Type V collagen was 
purified from amnionic pepsin digests by the 
outlined procedure. 
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stirred for 24 hours. The precipitate which formed was col-
lected by centrifugation and resuspended in 0.05 M Tris-HCl 
pH 7.4 containing 1 M NaCl. The Type V collagen in this 
solution was precipitated by adjusting the NaCl concentration 
to 4.5 M. The precipiate collected by centrifugation was 
dissolved in 0.1 M acetic acid and the collagen was repre-
cipitated by adding NaCl to 1.2 M. The precipitate formed 
was collected and resuspended in 0.05 M Tris-HCl pH 7.4 
containing 0.1 M NaCl and was dialyzed against 0.01 M Tris-
HCl pH 8.6 containing 0.02 M NaCl and 2 M urea. The pre-
cipitate formed during dialysis was collected and dialyzed 
against 0.05M acetic acid and lyophilized. Aliquots of eaeh 
purification step were analyzed by SDS-PAGE by the method 
of Neville (1971) using 6% polyacrylamide slab gels. 
14
c-Acetylation of Types I and V Collegens 
Types I and V collagens were labeled with 14c-acetic 
anhydride. The labeling procedure utilizes an acetylation 
reaction which adds a 14c-acetate group to the epsilon 
amino groups of lysine residues in the triple helical 
region of the collagen molecule (Gisslow and McBride 1975). 
Purified collagen was suspended in 0.01% acetic acid at a 
concentration of 2 mg/ml; a typical reaction employed a 
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total of 200-300 mg of collagen. Prior to addition of the 
acetylating agent, the pH of the collagen solution was ad-
justed to 8 by the slow addition of 1 M K2HP0 4 . 1-
14
c-acetic 
anhydride, 1 mCi in 1.5 ml of benzene, was added dropwise 
over the course of 2 hours, the pH was maintained at 8 during 
the course of the reaction by addition of 1N NaOH. After 
this time the solution was acidified with glacial acetic 
acid to pH 4, dialyzed exhaustively against deionized water 
and lyophilized. A 2 mg sample of the dried protein was 
hydrolyzed in 0.5 mls of Digestol at 60°C for 3 hours and 
the specific activity of the substrate was determine. Ace-
tylation of Type I collagen yielded a substrate with a 
specific activity of 1.41 x 106 dpm/mg; the Type V sub-
~strate had a specific activity of 1.12 x 106 dpm/mg. All 
substrates were stored at -20°C. 
Type I Collagenase Assay 
Type I collagenase activity was measured according to 
Lindblad and Fuller (1982). Lyophilized 14C-labeled Type I 
collagen was suspended in 0.01% acetic acid at a concentra-
tion of 2 mg/ml. Immediately prior to use, this solution 
was diluted with 0.1 M Tris-HCl pH 7.6 containing 0.4 M 
NaCl and 0.01 M Cac1 2 so that 0.05 ml contained approxi-
mately 20,000 counts per minute (cpm). In a typical assay, 
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0.2 ml of activated culture medium was mixed with 0.1 ml of 
0.05 M Tris-HCl pH 7.5 containing 0.005 M CaC1 2 . Each 
assay contained 0.05 ml of the diluted substrate solution 
and was incubated at 35°C for 1 hour. The assay was termin-
ated by addition of 0.1 ml of 0.1 M EDTA containing 150 µg 
of carrier Type I collagen. This mixture was incubated for 
an additional 30 minutes to assure complete denaturation of 
degraded substrate, and then cooled to 15°C for 5 minutes. 
Native substrate was precipitated by the addition of 0.8 ml 
of a 4:1 (V/V) dioxane/methanol solution. This mixture was 
centrifuged for 25 minutes at 6000 Xg and 0.8 ml of the 
supernatant was mixed with 5 ml of Atomlight to determine 
soluble radioactivity. 
Preparation of a Type V Collagen Degrading Activit y 
Type V collagen degrading activity was obtained from 
in vivo activated alveolar macrophages maintained in cul-
ture using the method of Mainardi et al (1980a). An adult 
female albino rabbit (3 kg) was injected with 0.2 ml of 
Freunds complete adjuvant in the ear vein. Two weeks later 
the rabbit was anesthetized and its lungs were surgically 
removed. Alveolar macrophages were washed out of the lungs 
by lavage using sterile PBS, the lavage treatment was re-
peated eight times using a total of 200 ml of PBS. The 
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collected cells were washed three times in DME media con-
taining 100 U penicillin/ml and 100 µg streptomycin/ml. 
Cells were plates out in 100 x 20 mm culture dishes at 
densities of 1 x 107 cells/dish in 10 ml of DME media supple-
mented with 10% FCS, 100 U penicillin/ml, 100 µg streptomycin/ 
ml and 2.5 µg Fungizone/ml. Cells which adhered to the plates 
after 24 hours of growth in serum containing medium were used 
for the remainder of the procedure. Plates were maintained 
at 37°C in a humidified environment containing 5% co2 and 95% 
air. Each plate contained 10 ml of serum-free DME media 
which was collected and replaced with fresh media every 2 
days for 2 weeks. The collected media was concentrated to 
10 ml by pressure dialysis using an Amicon PM-10 ultrafil-
tration membrane. A 0.05 ml aliquot of this preparation 
degraded approximately 4 µg of Type V collagen substrate in 
5 hours at 30°C pH 7.5. 
Type V Collagenase Assay 
Type V collagen degrading activity was measured using 
an improved assay which utilized a soluble substrate, non-
denaturing conditions, and dioxane/methanol which preci-
pitates native substrate molecules. Lyophilized 14c-
labeled Type V collagen was suspended in 0.01% acetic 
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acid at a concentration of 1 mg/ml. Immediately prior to 
use, this solution was diluted with 0.1 M Tris-HCl pH 7.6 
containing 0.2 M NaCl and 0.01 M CaC1 2 so that 0.05 ml con-
tained 20,000 cpms (20 µg substrate). Activated culture 
medium or other enzyme solutions were mixed with 0.05 M 
Tris-HCl pH 7.5 containing 0.005 M CaC1 2 in a final reaction 
volume of 0.3 ml. A volume of 0.05 ml of the diluted sub-
strate solution was added to each assay tube and incubated 
at 30°C for 12-24 hours. The assay was terminated by cooling 
the samples to 15°C for 5 minutes and adding 0.1 ml of ice 
cold dioxane/methanol (4:1 V/V). Precipitated native sub-
strate was separated from degraded substrate by centrifuga-
tion at 6000 Xg for 25 minutes at 4°C. A 0.2 ml aliquot of 
~the supernatant was mixed with 5 ml of Atomlight to deter-
mine soluble radioactivity. 
Elastase Assay 
Insoluble elastin powder, purchased from Sigma Chemical 
Company, was labeled using 3H-sodium borohydride by the 
method of Stone et al (1982). The lyophilized labeled 
elastin was suspended in 0.05 M Tris-HCl pH 7.5 containing 
0.005 M CaC12 at a concentration of 1 mg/ml; 0.25 ml of 
this suspension was added to 1 ml microcentrifuge tubes. 
Aliquots of the cell sonicates (0.1 to 0.5 ml) and 0.05 
........ 
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M Tris-HCl pH 7.5 containing 0.005 M CaC1 2 were added to the 
microcentrifuge tubes in a final reaction volume of 1.0 ml. 
The reaction mixtures were incubated at 37°C for 24 hours 
without agitation, cooled on ice, and centrfuged in a Fischer 
Model 59 microcentrifuge for 2 minutes at 7000 Xg. A 0.2 ml 
aliquot of the supernatant was removed and mixed with 5 ml 
of Atomlight to determine soluble radioactivity. 
Ion Exchange Chromatography 
DEAE cellulose ion exchange chromatography was utilized 
to separate Types I and V collagen degrading activities 
secreted by DLD-1 colon carcinoma cells. DEAE cellulose 
(Whatman DE-52) was suspended in 0.05 M Tris-HCl pH 8.3 
containing 0.005 M CaC1 2 and 0.02% NaN 3 , packed into a 
column 1.6 x 13 cm and allowed to equilibrate at 4°C by 
washing with several volumes of buffer. Pooled serum-free 
media from 900 100 x 20 mm culture dishes of late log phase 
DLD-1 cells were concentrated by pressure dialysis using 
an Amicon PM-10 ultrafiltration membrane and dialyzed 
against 10 liters of column buffer. The sample, approxi-
mately 100 ml, was trypsin activated as previously de-
scribed and centrifuged for 10 minutes at 8000 Xg to 
remove any precipitate which had formed during concen-
tration and dialysis. The supernatant was then applied to 
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the column at a flow rate of 25 ml/hour and the column 
was washed with buffer until absorbance at 280 nm of the 
effluent returned to baseline. Bound proteins were 
eluted in a linear gradient from 0.0 to 1.0 M NaCl in 
column buffer. The gradient was run over the course of 
16 hours using an Ultrograd Gradient Mixer (LKB Bromma, 
Sweden). 'Ihe total gradient volume was 480 mls. Six ml 
fractions were collected and monitored for absorbance at 
280 nm and assayed for Type I and V collagenase activity. 
Gel Filtration Chromatography 
Molecular weights of Type I and V collagenolytic 
~activities were determined using Ultrogel AcA44 gel 
filtration medium. The column material was packed into 
a column 1.6 x 90 cm at 4°C and equilibrated in 0.05 M 
Tris-HCl pH 7.6 containing 0.01 M CaC12 and 0.02% NaN3 . 
The flow rate of the column was kept constant at 8 ml/ 
hour. The column was calibrated using the globular 
protein standards bovine serum albumin, ovalbumin, 
carbonic anhydrase and ribonuclease, 1 mg of each 
standard was chromatographed separately. Blue Dextran 
2000 was used to determine the void volume (V ). Frac-
o 
tions of 2 ml were collected and the absorbance at 280 
run was monitored. Peaks of Type I or TypP V collagenolytic 
activity from the DE-52 chromatogram were concentrated to 
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1 ml by pressure dialysis using an Amicon PM-10 ultra-
filtration membrane. These samples were applied to the 
column. Fractions of 2 ml were collected, the absorbance 
monitored at 280 nm was monitored, .and the fractions were 
assayed for Ty..pes I and V collagenase activity. 
Statistical Analysis 
The statistical methods used in this study were 
obtained from the statistics textbook, "Introduction to 
Applied Statistics", (Lentner, M., 1976). 
1. Mean (X) = EX. /n 
l 
n = sample size 
X. = ith sample value 
l 
2. Standard Deviation( s) ~ Exi - X) 2 I (n - 1 )! I 
3. Unpaired Student t test = t = (Xl x2) [i: 8~1;2 
n = sample size of 1 group 
degrees of freedom = 2(n-1) 
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RESULTS 
Purification of Type V Collagen 
Collagenous proteins present in an insoluble form in 
the extracellular matracies of many tissues can be 
extracted in a soluble form by limited digestion of the 
tissue with pepsin. This procedure was employed to 
solubilize Type V collagen from human amnionic membranes. 
Pepsin soluble collagens can be separated by differential 
precipitation with NaCl. This procedure takes advantage of 
solubility differences between the five genetically dis-
tinct collagen types. Interstitial collagen Types I and 
~III in the amnionic pepsin digest were precipitated at 
low ionic strength (0.8M NaCl). Type V collagen preci-
pitated when the ionic strength of the solution was 
raised to 1.2M NaCl. This precipitate was suspended in 
neutral salt buffer to inactivate any residual pepsin 
and the Type V collagen was reprecipitated by the addition 
of NaCl to 4.5 M. The 4.5 M NaCl precipitate was suspended 
in neutral salt buffer and dialyzed against a buffer of 
low ionic strength. This step separates Type V collagen 
from low molecular weight protein fragments which are 
soluble in low ionic strength solutions. 
The precipitate formed during dialysis contained 
purified Type V collagen. The purification began with 
745 grams of amnionic membranes (wet weight) and pro-
duced 350 mg of Type V collagen, a yield of 0.05%. The 
purity of the preparation was monitored by SDS-PAGE at 
various stages of the purification as shown in Figure 2. 
The electrophoretic pattern of purified Type I collagen 
is shown for comparison (Lane 1). The whole pepsin 
digest was found to contain both interstitial and Type V 
collagens (Lane 2). The precipitate which formed at 
0.8M NaCl contained predominately Type I collagen and 
was devoid of Type V collagen (Lane 3). Pepsin added 
at the start of the purification was separated from 
~Type V collagen when the NaCl concentration was raised 
to 1.2M. Type V collagen precipitates at this ionic 
strength and the pepsin remains soluble (Lane 5). The 
Type V collagen which was purified by pepsin digestion 
and differential NaCl precipitation consisted of two~ 
chains,o\ l(V) and<1'\2(V) present in an approximate 2:1 
ratio (Lane 7). The molecular weights of these J\chains 
were estimated to be 117,000 and 105,500 using molecular 
weight standards (Lane 8). 
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Figure 2. SOS Polyacrylamlde Slab Gel Electrophoresis of Type V Collagen 
Purtflcatlon. Aliquots of different stages of the purtflcatton 
were electrophoresed and protein bands were vleuallzed by 
stalnlng wtth Coomatsee Orllltant Olue. (1) Purlfled Type I 
collagen standard, (2) amntonlc pepeln digest, (3) 0.8M NaCl 
prectpltate, (4) pepsin ~tandard, ' (5) 1.2M NaCl supernate, 
(6) 4.5M NaCl precipitate, (7) Isolated Type V colla~en, 
(8) molecular weight standards. 
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Type V Collagenase Assay 
An assay for measuring Type V collagen degrading 
activity was developed. Purified Type V collagen was 
labeled with 14c-acetic anhydride. This compound acetylates 
the epsilon amino groups of lysine residues in collagen. 
The labeled Type V collagen had a specific activity of 
6 1.12 x 10 dpm/mg. The assay was performed at an incuba-
tion temperature of 30°C. This is several degrees below 
the point at which the Type V collagen triple helix 
begins to denature (Rhodes and Miller, 1978). The pre-
cipitating solvent dioxane/methanol (4:1, v/v) was used 
to separate native substrate molecules from degraded sub-
strate molecules. This solvent has been used previously 
in Type I collagenase assays (Lindblad and Fuller, 1982). 
The solubility of native and denatured Type V collagen 
substrate in dioxane/methanol was determined. Increasing 
volumes of the precipitating solvent were added to native 
substrate (30°C) and substrate which had been denatured by 
heating at 60°C for 30 minutes. The solutions were 
centrifuged and the amount of substrate which precipitated 
was determined (Figure 3). Native substrate molecules 
precipitated at much lower dioxane/methanol concentration 
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Figure 3. Solubility of Native and Denatured Radiolabeled 
Type V Collagen in Dioxane/Methanol/Water. 
Increasing volumes of a dioxane/methanol 
solution (4:1, v/v) were added to native (30°C) 
and heat denatured (60°C for 30 mi ns.) 
14c-Type V collagen, centrifuged and soluble 
radioactivity was determined. 
-....._ 
than denatured substrate molecules. The difference in 
their solubilities was greatest between 23%-46 % dioxane/ 
methanol. 
The solubility of enzymatically produced Type V 
collagen reaction products in dioxane/methanol were 
determined. Native substrate was degraded by three 
different collagenases, Clostridium histolytium colla-
genase. (E.C. 3.4.24.3), rabbit alveolar macrophage 
collagenase, and collagenase obtained from the media 
of cultured DLD-1 colon carcinoma cells. The enzyme-
substrate solutions were incubated at 30°C for six hours 
then increasing volumes of dioxane/methanol were added. 
Following centriguration, the solubility of the reaction 
products were determined (Figure 4). When the substrate 
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was degraded by bacterial collagenase soluble radio-
activity was highest at 29% dioxane/methanol. Following 
incubation with alveolar macrophage and DLD-1 collagenases 
soluble radioactivity was highest at 13% dioxane/methanol. 
To optimize the detection of enzyme activity while pre-
cipitating the majority of the native substrate molecules 
23% dioxane/methanol was chosen as the standard concen-
tration to be used in the assay. At this concentration 
70% of the native substrate is precipitated and appreci-
---
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Figure 4. Solubility of Radiolabeled Type V Collagen 
Degradation Products Formed by Three Collagenases 
in Dioxane/Methanol/Water. 14 c-Type V collagen 
(20 µg) was incubated with three different 
collagenases; bacterial collagenase, alveolar 
macrophage collagenase and DLD-1 colon carcinoma 
collagenase at 30°C. Increasing volumes of 
dioxane/methanol · (4:1, v/v) were added, centri-
fuged and soluble radioactivity was determined. 
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able amounts of enzymatic activity can be detected. 
As shown on Figure 5,degradation of the substrate by 
alveolar macrophage collagenase was linear with time. 
Approximately 20% of the added substrate (20 µg) had been 
degraded after five hours of incubation at 30°C and pH 7.5. 
Levels of Collagenolytic and Elastinolytic Activities 
In Normal Fibroblasts, DLD-1, and B16-F10 Cells 
Late log phase cultures of DLD-1 colon carcinoma 
cells, B16-F10 murine melanoma cells, and normal dermal 
fibroblasts were maintained in serum-free media for 24 
hours. The cells and media were processed for enzyme 
assays, protein and DNA determinations as described in 
the Experimental Section. DLD-1 cells and normal fibro-
blasts produced comparable levels of Type I collagenolytic 
activity (Table 1). B16-Fl0 cells produced approximately 
half as much activity. Normal fibroblasts produced the 
highest level of Type V collagenolytic activity (0.48 ± 
0.14 µg collagen degraded/mg protein/hr), DLD-1 cells 
produced about half this amount of activity while Bl6-Fl0 
cells only degraded 0.13 ± 0.06 µg collagen/mg protein/hr. 
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Figure 5. Degradation of Radiolabeled Type V Collagen 
by Alveolar Macrophage Collagenase As A 
Function of Time. 14c-Type V collagen (20 µg) 
was incubated with alveolar macrophage collagenase 
at 30°C for various lenghts of time and the amount 
of substrate degraded was determined. 
Table 1. 
CELL LINE 
Levels of Type I Collagenase,~Type V Collagenase, Cellular Elastace, and 
Media Elastase Produced by DLD-1 Colon Carcinoma Cells, B16-F10 Melanoma 
Cells, and Normal Dermal Fibroblasts. 
ENZYME ACTIVITY 
µg substrate degraded/hr/mg protein 
TYPE I TYPE V CELLULAR MEDIA 
COLLAGENASE COLLAGEN ASE ELASTASE ELASTASE 
DLD-1 Colon 
Carcinoma 7 .18 ± 0 .80 0.25 ± 0.03 0.25 ± 0.04 31.97 ± 2.80 
B16-F10 
Melanoma 3.70 ± 0.26 0.13 ± 0.06 0.38 ± 0.09 0.55 ± 0.09 
Normal Dermal 
Fibroblast 7.27 ± 1.66 0.48 ± 0.14 0.77 ± 0.26 1.17 ± 0.32 
Results are expressed as the mean ± S.D. with an n = 4. 
C.11 
(j) 
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The Triton X-100 cell extracts and culture media from 
the three cell lines were assayed for elastin degrading 
activity. DLD-1 cells produced the highest levels of 
elastinolytic activity of the three cell lines, this 
activity was found predominately in the media (>99% of the 
total). Fibroblasts contained the second highest level of 
elastinolytic activity, approximately 40% of the activity 
was cell-associated and 60% was in the media. The elastin 
degrading activity from Bl6-F10 cells was distributed 
between the cellular compartment and the media in the same 
ratio as the fibroblast activity. 
DEAE Ion Exchange Chromatography 
Media containing DLD-1 collagen degrading activities 
was collected and several attempts were made to separate 
Type I and Type V collagen degrading activities using gel 
filtration chromatography. These attempts proved to be 
unsuccessful, each chromatogram revealed numerous peaks 
of Type I and Type V collagen degrading activity and 
adequate resolution of the two activities was not possi-
ble. DEAE cellulose ion exchange chromatography was then 
employed to separate Type I and Type V collagen degrading 
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activities. DEAE cellulose chromatography was used to 
separate these two activities produced by cultured macro-
phages (Mainardi et al, 1980a). Serum-free media from 900 
plates of late log phase DLD-1 co-on carcinoma cells 
was used as the source of collagenase activity. As seen 
in Figure 6 approximately half of the media proteins bound 
to the DE-52 column and half passed through the column. 
The fractions containing the protein which did not bind to 
the resin were analyzed and only Type V collagen degrading 
activity was detected. The proteins which bound to the 
resin were eluted with a 400 ml linear NaCl gradient 
(0-0.3M). This was found to be insufficient to elute all 
the proteins, a second gradient of 0.3M to 1.0M NaCl was 
used to elute the remainder of the proteins. The first 
peak of protein eluted between 0.2M and 0.3M NaCl, these 
fractions were found to contain only Type I collagen 
degrading activity. The proteins which eluted in the 
second gradient between 0.3M and 0.5M NaCl were analyzed 
for collagenase activity and both Type I and Type V 
collagen degrading activity were detected. 
Gel Filtration Chromatography 
The three peaks of collagen degrading activity gen-
erated by DEAE cellulose chromatography were further 
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Figure 6. DEAE Cellulose Chromatography of Concentrated 
DLD-1 Colon Carcinoma Cell Serum-Free Media. 
Serum-free media from 900 100 x 20 mm culture 
dishes of late log phase DLD-1 cells was con-
centrated and applied to a 1.5 x 13 cm column 
of DE-52 equilibrated in 0.05M Tris~Cl pH 8.3 
containing 0.005M CaCl2 and 0.02 % NaN3 . The 
bound proteins were eluted in two NaCl gradi-
ents, one from 0 to 0.3M NaCl and the second 
gradient from 0.3M to 1.0M. Six ml fractions 
were collected and monitored for absorbance at 
280 nm (Panel B) and analyzed for Type I and 
Type V collagen degrading activity (Panel A). 
The fractions were combined to form three pools 
according to enzyme activity (I, II, III) as 
indicated. 
........ 
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fractionated by gel filtration chromatography on Ultrogel 
AcA44. The column was calibrated for molecular weight 
determination using Blue Dextran, bovine serum albumin, 
ovalbumin, pepsin, carbonic anhydrase, and ribonuclease A. 
The fractions containing the protein which did not bind 
to the DE-52 column, Pool I, were concentrated and applied 
to the Ultrogel AcA44 column. This pool was fractionated 
into two peaks of Type V collagen degrading activity 
(Figure 7). The first peak eluted in the void volume (V
0
), 
this peak represented a minor portion of the total protein 
and enzyme activity. Its molecular weight (M.W.) was 
larger than 200,000 daltons, the exclusion limit for Ultro~ 
gel AcA44. The second peak of Type V collagen degrading 
activity generated by Ultrogel chromatography had an 
elution volume corresponding to a M.W. of 54,000 daltons. 
This peak constituted the majority of the enzyme activity 
added and only a minor portion of the total protein in 
Pool I. The majority of the protein in Pool I was of low 
M.W., approximately 10,000 daltons. 
Pool II, the major peak of Type I collagen degrading 
activity from the DE-52 chromatogram, was also chromato-
graphed on Ultrogel. It was separated into two peaks of 
protein and both contained Type I collagen degrading 
activity (Figure 8). The V contained approximately half 
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Figure 7. Ultrogel AcA44 Gel Filtration Chromatography of Pool I. 
All fractions in Pool I of the DE-52 chromatogram were 
concentrated by pressure dialysis to 1.5 mls and applied 
to a column (1.6 x 90 cm) of Ultrogel AcA44 equilibrated 
in 0.05M Tris-HCl . pH 7.5 containing O.OlM CaCl2 and 0.02% 
NaN3. Fractions of 1.7 mls were collected and monitored 
for absorbance at 280 nm and for Type V collagenase 
activity. 
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Figure 8. Ultrogel AcA44 Gel Filtration Chromatography of Pool II. 
All fractions in Pool II of the DE-52 chromatogram were 
concentrated by pressure dialysis to 1.5 mls and applied 
to a column (1.6 x 90 cm) of Ultrogel AcA44 equilbrated 
with 0.05M Tris-HCl pH 7.5 containing O.OlM CaCl2 and 
0.02% NaN3. Fractions of 1.7 mls were collected and 
monitored for absorbance at 280 nm and for Type I 
collagenase activity. 
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of the total enzyme activity and about 30% of the total 
protein applied to the column. The second peak of enzy-
matic activity eluted in the 60,000 dalton M.W. range. 
Pool III which eluted from the DEAE cellulose column 
during the 0.3M to 1.0M NaCl gradient, was fractioned into 
three peaks of enzyme activity by chromatography on Ultro-
gel AcA44 (Figure 9). The V fractions from this chroma-
o 
togram contained the majority of the protein that was 
loaded on the column. Both Type I and Type V collagen 
degrading activities were detected in these fractions. 
The second of the three peaks generated contained only 
Type V collagen degrading activity and had a M.W. of 
approximately 80,000 daltons. The final peak which eluted 
in the 35,000 dalton M.W. range contained Type I co l lagen 
degrading activity. 
Inhibition of Types I and V Collagen Degrading Activities 
Concentrated serum-free media from DLD-1 colon cari-
noma cells were used as the source of Type I and Type V 
collagen degrading activities. Fetal calf serum, EDTA, 
PMSF, dithiothreital (DTT), and N-ethylmaleimide (NEM) 
were tested for their ability to inhibit DLD-1 collagen 
degrading activities using the standard enzyme assays 
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Figure 9. Ultrogel AcA44 Gel Filtration Chromatography 
of Pool III. All fractions in Pool III of 
the DE-52 chromatogram were concentrated by 
pressure dialysis to 1.5 mls and applied to 
a column (1.6 x 90 cm) of Ultrogel AcA44 
equilibrated with 0.05M Tris-HCl pH 7.5 
containing O.OlM CaCl2 and 0.02 % NaN3. 
Fractions of 1.7 mls were collected and 
monitored for Type I and Type V collagenase 
activity (Panel A) and absorbance at 280 nm 
(Panel B). 
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(Table 2). Both Type I and Type V collagen degrading 
activities were inhibited by serum and EDTA, the metallo-
proteinase inhibitor. The serine protease inhibitor PMSF 
had no effect on Type V collagen degrading activity and 
reduced the Type I collagen degrading activity by only 18%. 
DTT, which reduces disulfide bonds and maintains sulfhydryl 
groups in a reduced state, blocked 41% and 32% of Type I 
and Type V collagen degrading activities, respectively. 
NEM, which reacts with free sulfhydryl groups, had no effect 
on either enzyme activity. 
Effects of DMF on the Production of Type I and Type V 
Collagenase, Cellular, and Media Elastase Activities 
By DLD-1 Colon Carcinoma Cells 
The effect of DMF on the production Type I and Type V 
collagenase and elastase activities by DLD-1 cells was 
determined using late log phase cultures. The production 
of these enzymatic activities was measured over a 24 hour 
period. Enzyme activity was normalized using total cellu-
lar protein and DNA values (Table 3). DMF caused a 20% 
increase in Type I collagenase activity over control 
cultures when the activity was expressed per mg of protein. 
J 
Table 2. Inhibition of Type I and Type V Collagen Degrading Activities 
by Protease Inhibitors. 
PERCENT INHIBITION 
INHIBITOR CONCENTRATION TYPE I COLLAGENASEl TYPE V COLLAGENASE2 
SERUM 5% 78 70 
EDTA 10 MM 73 68 
PHSF 1 HM 18 0 
DTT 10 HM 41 32 
NEM 10 HM 0 0 
Crude DLD-1 colon Carcinoma Serum-Free Media was used as the source of 
collagenase activity in both assays. 
1. Type I collagenase assay was incubated at 35°C for 1 hour. 
2. Type V collagenase assay was incubated at 30°C for 12 hours. 
m 
00 
(1) Table 3. Effect of DMF on Type I pollagenase, Type V Collagenase, Celluar 
Elastase, and Media Elastase Production by DLD-1 Colon Carcinoma Cells. 
ENZYME ACTIVITY 
ACTIVITY µg substrate degraded/hr/mg protein µg substrate degraded/hr/mg DNA 
MEASURED 
CONTROL DMF CONTROL DMF 
Type I 
Collagenase 7.18 ± 0.80 8.60 ± 0.50* 311 ± 33 773 ± 167* 
Type V 
Collagenase 0.25 ± 0.03 0.37 ± 0.06* 10 ± 1 34 ± 5* 
Cellular 
Elastase 0.25 ± 0.04 0.32 ± 0.02* 10 ± 1 30 ± 4* 
Media 
Elastase 31. 97 ± 2. 80 22. 38 ± 11. 9 1345 ± 108 2066 ± 1034 
Results are expressed as the mean ±S.D. with an n = 4. 
(1) Cells were treated with 0.8% DMF for four passages prior to analysis. 
* Significantly greater than control, p < 0.05 determined by unpaired Student's 
t test. 
en 
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The increase due to DMF was 148% when DNA was 
used to normalize the enzyme values. Both values for Type 
I collagenase activity in DMF cultures were significantly 
higher than control values (p < 0.05). Type V collagenase 
activity increased 44% and 220% due to DMF treatment when 
enzyme activity was expressed per amount of protein and 
DNA,respectively. DLD-1 cellular elastase activity also 
increased as a result of DMF treatment. Cellular elastase 
activity per mg protein increased 31% while elastase 
activity per µg DNA increased 192%. Both values were 
significantly higher than control (p < 0.05). Media 
elastase activity per mg protein dropped by 30% in 
response to DMF. This decrease was not found to be signi-
ficant (p < 0.05). Media elastase activit y expressed per 
µg DNA increased 53% when the cells were treated with DMF. 
This value for enzyme activity in DMF treated culture was 
significantly higher than control cultures (p < 0.05). 
To deter~ine if these increases in activity were associ-
ated with alterations in the levels of cellular protein, DNA 
and RNA the levels of these cellular constituents were deter-
mined. Cells were grown in media containing 0.8% DMF for 
four passages prior to analysis. DMF caused a significant 
rise in the cellular levels of protein and RNA over con-
trols (p < 0.05). DMF cells contained significantly less 
DNA than control cells (p < 0.05) (Table 4). 
Effect of DMF on the Incorporation of 
3H-glycine into Protein 
The effect of DMF on the capacity of DLD-1 cells 
to synthesize and secrete protein was analyzed by 
measuring the rate of incorporation of 3H-glycine into 
TCA insoluble cell and media proteins. Determinations 
were made after three and six hours of growth in media 
containing 5 µCi 3H-glycine/ml. The results of these 
experiments were normalized in two ways; per amount of 
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cellular protein and DNA. DMF treated cells incorporated 
3H-glycine into cellular protein at a slower rate than 
...._ 
control cells after three hours of growth in 3H-glycine 
containing media (Table 5). This decrease was signifi-
cant only when the values were expressed per unit of DNA 
(p < 0.05). However, after six hours of incubation, the 
DMF treated cells were incorporating label into cellular 
protein at a faster rate than controls. The DMF values 
were significantly greater than controls by both units 
of measure (p < 0.05). 
Analysis of media proteins revealed that DMF treated 
cells were secreting 3H-glycine containing protein into 
Table 4. 
TREATMENT 
Control 
Effect of DMF(l) on Protein, DNA, and RNA Content 
of DLD-1 Colon Carcinoma Cells. 
CELLULAR CONTENTS 
mg PROTEIN/ lJg DNA/C~LL lJg RNA/CELL 
CELL x 10-7 x 10- x 10-6 
6.89 ± 0.80 1. 64 ± o. 22 x 6.11 ± 2.20 
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DMF 8 .13 ± 0.50* o. 87 ± 0.12 9.52 ± 0.83* 
Results are expressed as the mean ±S.D. with 
an n = 4. 
(1) Cells were treated with 0.8% DMF for four passages prior 
to analysis. 
* Significantly greater than control, p < 0.05 determined 
by unpaired Student's t test. 
x Significantly greater than DMF, p < 0.05 determined by 
unpaired Student's t test. 
Table 5. 
LENGTH OF 
Effect of DMF(l) on the Incor~oration of 3H-glycine into Cellular Protein of 
DLD-1 Colon Carcinoma Cells. 
RATE OF INCORPORATION OF 3H-GLYCINE 
INCUBATION dpm/mg Protein/hr x 10-3 dpm/µg DNA/hr x 10-3 
IN LABEL 
CONTAINING 
MEDIA CONTROL DMF CONTROL DMF 
3 Hours 553 ± 28 539 ± 122 433 ± 2x 331 ± 6 
6 Hours 528 ± 41 634 ± 57* 324 ± 2 404 ± 3* 
Results are expressed as the mean ±S.D. with an n = 3. 
(1) Cells were treated with 0.8/. DMF for four passages prior to analysis. 
* Significantly greater than control, p < 0.05 determined by unpaired Student's t test. 
x Significantly greater than DMF, p < 0.05 determined by unpaired Student's t test. 
--l 
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the media at a slower rate than controls at three hours 
(Table 6). The rate of secretion of labeled proetin by 
DMF treated cells was significantly slower than control 
when expressed per unit of DNA but was not significantly 
different per unit of protein (p < 0.05). At six hours, 
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the situation had reversed, DMF treated cells were secreting 
labeled protein at a faster rate than controls. This in-
crease was significant only when the data was expressed 
per unit of DNA (p < 0.05). 
Effect of Cycloheximide on the Synthesis of Connective 
Tissue Degrading Enzymes by Control and DMF Treated 
DLD-1 Cells 
Control and DMF treated DLD-1 cells were treated with 
cycloheximide to determine if the effects of DMF were 
dependent on the synthesis of protein. Cells were exposed 
to 1 µg cycloheximide/ml for the 24-hour period during 
which enzyme production was quantified. Treatment of DMF 
treated DLD-1 cells with cycloheximide resulted in a small 
decrease in Type I collagenolytic activity expressed per 
unit of protein and an insignificant increase in activity 
per unit of DNA (p < 0.05) (Table 7). Cyclobeximide bad 
the same effect on control cells; synthesis of Type I 
Table 6. 
LENGTH OF 
Effect of DMF(l) on the Incor~oration of 3H-glycine into Media Protein of 
DLD-1 Colon Carcinoma Cells. 
RATE OF INCORPORATION OF 3H-GLYCINE 
INCUBATION dpm/mg Protein/hr dpm/µg DNA/hr 
IN LABEL 
CONTAINING 
MEDIA CONTROL DMF CONTROL DMF 
3 Hours 4811 ± 455 3450 ± 1078 374 ± 46 x 213 ± 65 
6 Hours 5750 ± 1014 7309 ± 1110 353 ± 65 464 ± 47* 
Results are expressed as the mean ±S.D. with an n = 3. 
(1) Cells were treated with 0.8% DMF for four passages prior to analysis. 
* Significantly greater than control, p < 0.05 determined by unpaired Student's t test. 
x Significantly greater than DMF, p < 0.05 determined by unpaired Student's t test. 
'I 
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Table 7. 
TREATMENT 
Control 
Control + 
Effect of Cycloheximide(l) on Type I Collagenase 
Production by Control and DMF Treated(2) DLD-1 
Colon Carcinoma Cells. 
TYPE I COLLAGENASE ACTIVITY 
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µg collagen degraded/hr Ilg collagen degraded/hr 
/mg protein /mg DNA 
7 .18 ± 0.8 311 ± 33 
Cycloheximide 6.27 ± 0.7 458 ± 145 
DMF 8.60 ± 0.5* 773 ± 167* 
........ 
DMF + 
Cycloheximide 8.54 ± 2.7 867 ± 200* 
Results are expressed as the mean ± S.D. with an 
n = 4. 
(1) Cells were treated with 1 µg cycloheximide/ml. 
(2) Cells were treated with 0.8% DMF for four passages prior 
to analysis. 
* Significantly greater than control or control + cycloheximide, 
p < 0.05 determined by unpaired Student's t test. 
....._ 
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collagenolytic activity was diminished but not comnletely 
abolished. Cycloheximide treatment could not inhibit the 
increase in Tvpe I collagenolytic activity nroduced by 
DMF treatment. 
Treatment of DMF and control DLD-1 cells with 
cycloheximide effected the synthesis of Type V collagen-
olytic activity in a manner similar to that seen with 
Type I collagenolytic activity. Increases in Type V 
collagenolytic activity due to DMF were still present 
when DMF and control cells were treated with cyclohexi-
mide; however, the magnitude of the increase was less 
(Table 8). DMF treated cells treated with cycloheximide 
produced significantly more Type V collagenolytic activ-
ity than control cells treated with cycloheximide 
(p < 0.05). 
A similar pattern of reduction in the DMF effect 
upon treatment with cycloheximide was seen with cellular 
elastase activity (Table 9). DMF treated cells treated 
with cycloheximide produced significantly more cellular 
elastase activity than control cells treated with cyclo-
heximide when the activity was expressed per unit of DNA 
(p < 0.05). The increase was not significant when 
expressed per unit of protein. 
Table 8. 
TREATMENT 
Control 
Control + 
Effect of Cycloheximide(l) on Type V Collagenase 
Production by Control and DMF Treated(2) DLD-1 
Colon Carcinoma Cells. 
TYPE V COLLAGENASE ACTIVITY 
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µg collagen degraded/hr µg collagen degraded/hr 
/mg protein /mg DNA 
0.25 ± 0.03 10. 6 7 ± 1.24 
Cycloheximide 0.22 ± 0.01 16. 52 ± 4.40 
DMF 0.37 ± 0.06* 34.20 ± 5.20* 
---
DMF + 
Cycloheximide 0.30 ± 0.06* 31.30 ± 5 .16* 
Results are expressed as the mean ± S.D. with an 
n = 4. 
(1) Cells were treated with 1 µg cycloheximide/ml. 
(2) Cells were treated with 0.8% DMF for four passages prior 
to analysis. 
* Significantly greater than control or control + cycloheximide, 
p < 0.05 determined by unpaired Student's t test. 
Table 9. 
TREATMENT 
Control 
Control + 
Effect of Cycloheximide(l) on Cellular Elastase 
Production by Control and DMF Treated(2) Colon 
Carcinoma Cells. 
ELASTASE ACTIVITY 
79 
µg elastin degraded/hr µg elastin degraded/hr 
/mg protein /mg DNA 
0.25 ± 0.04 10.30 ± 1. 70 
Cycloheximide 0.23 ± 0.03 13.15 ± 1.90 
DMF 0.32 ± 0.02* 30.14 ± 4.10* 
......._ 
DMF + 
Cycloheximide 0.24 ± 0.06 24.77 ± 4.50* 
Results are expressed as the mean ± S.D. with an 
n = 4. 
(1) Cells were treated with 1 µg cycloheximide/ml. 
(2) Cells were treated with 0.8% DMF for four passages prior 
to analysis. 
* Significantly greater than control or control + cycloheximide, 
p < 0.05 determined by unpaired Student's t test. 
A markedly different result due to cycloheximide 
treatment was obtained when media elastase activity was 
measured. Treatment of control cells with cycloheximide 
resulted in a small decrease in media elastase activity 
per unit of protein and a small but insignificant 
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increase in activity per unit of DNA (p < 0.05) (Table 10). 
These results were analogous to those seen for Type I and 
Type V collagenase and cellular elastase. However, when 
DMF treated DLD-1 cells were treated with cycloheximide 
media elastase activity increased above the levels seen 
in cultures treated with DMF alone. These increases were 
significant when the activity was expressed per unit of 
protein and DNA (p < 0.05). 
Table 10. Effect of Cycloheximide(l) on Media Elastase 
Production by Control and DMF Treated(2) DLD-1 
Colon Carcinoma Cells. 
ELASTASE ACTIVITY 
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µg elastin degraded/hr µg elastin degraded/hr 
TREATMENT /mg protein /mg DNA 
Control 31.97 ± 2.8 1345 ± 108 
Control + 
Cycloheximide 30.70 ± 11. 0 1959 ± 91 4 
DMF 22.38 ± 11.9 2066 ± 1034 
DMF + 
Cycloheximide 52.68 ± 20.6 5151 ± 814* 
Results are expressed as the mean ± S.D. with an 
n = 4. 
(1) Cells were treated with 1 µg cycloheximide/ml. 
(2) Cells were treated with 0.8% DMF for four passages prior 
to analysis. 
* Significantly greater than control + cycloheximide, p < 0.05 
determined by unpaired Student's t test. 
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DISCUSSION 
Type V Collagen Purification and Type V Collagenase Assay 
In order to study the degradation of Type V collagen 
by tumor proteases a fairly large quantity of the protein in 
purified form was needed. Human placentas were a good 
source of Type V collagen since they were easily obtain-
able and contained fairly large quantities of collagenous 
proteins. Initial attempts to purify Type V collagen 
utilized the whole placenta. It was later found advan-
tageous to use only the amnionic membrane as the starting 
material since Type V collagen comprises a greater portion 
~of the total collagen present in anmions than in whole 
placentas (Sage and Bornstein, 1979). The exact molecular 
configuration of Type V collagen is not established, many 
preparations are composed of two different °'chains, 
°' l(V) and °' 2(V) in a 2: 1 ratio (Rhodes and Miller, 1978; 
Bentz et al, 1978; Burgeson et al, 1976). A third°' chain 
d\3(V) has been isolated from whole placenta but is 
absent from amnionic membranes (Sage and Bornstein, 1979). 
The Type V collagen purified in this study was of the con-
figuration cA l(V) 2 , <::\ 2(V). The molecular weights of the 
~chains are in close agreement with those reported by 
Rhodes and Miller (1978). The purified material was 
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labeled via an acetylation reaction and used as the sub-
strate in the Type V collagenase assay. Due to the high 
specific activity of the substrate (1.12 x 106 dpm/mg) only 
20 µg of collagen per assay was required to maintain a 
linear rate of degradation for the duration of the assay. 
The Type V collagenase assay developed offered several 
improvements over existing methods. This assay used 30°C 
as an incubation temperature. This temperature is several 
degrees below the temperature at which the Type V collagen 
triple helix begins to unfold (-33°C)(Rhodes and Miller, 
1978). Other assays used to measure Type V collagen de-
grading activity have used incubation temperatures of 
~32.5°C and 37°C (Mainardi et al, 1980a;Liotta et al, 1980). 
At these temperatures the Type V collagen helix may be 
starting to unfold or may be partially denatured and non-
specific degradation of the molecule may occur. Using 
30°C as the incubation temperature, degradation of the 
substrate by non-collagenase proteases is minimized. 
The degradation products formed during the reaction 
between enzyme and substarte were separated from non-
degraded substrate molecules using dioxane/methanol. This 
solvent precipitates native substrate molecules but not 
degraded denatured molecules. Dioxane was first used in 
in Type I collagenase assay by Terato et al (1976). The 
precipitating solvent was later modified by adding 
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methanol (4:1 dioxane/methanol)(Lindblad and Fuller, 1982). 
They found the addition of methanol increased the precipi-
tating efficiency of the solvent. The degradation products 
formed by three different collagenases exhibit differences 
in their solubility in dioxane/methanol. Mammalian colla-
genases are known to make one cleave in the collagen helix 
producing two specific reaction products (Gross and Nagai, 
1965) where as bacterial collagenase digests the molecule 
into many low molecular weight peptides (Nagai et al, 1960). 
The larger reaction products produced by the mammalian 
collagenases precipitated at lower dioxane/methanol con-
centrations than the more extensively degraded bacterial 
collagenase reaction products. The solubility differences 
between mammalian and bacterial collagenase reaction pro-
ducts are most likely due to the size of the fragment 
formed and the degree to which the fragment retains a 
helical structure. 23% dioxane/methanol was chosen as the 
standard concentration for the assay because native and 
denatured substrate molecules are maximally separated at 
this concentration and 25%-50% of the total enzyme activity 
produced by the mammalian collagenases could be detected. 
Others have used 50% dioxane to precipiate non-degraded 
Type V collagen (Mainardi et al, 1980a). In this assay, 
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the addition of 50% dioxane would allow the detection of 
less than 15% of the total radioactivity solubilized by 
DLD-1 and alveolar macrophage collagenases. The addition 
of small quantities of highly radioactive collagen and the 
improved precipitating solvent increases the sensitivity 
of the assay. If one unit of enzyme activity is defined 
as 1 µg of collagen degraded per minute at 30°C, the assay 
can detect as little as 13 mU of enzyme activity. Similar 
substrates and precipitating solvents have been used in 
Type I collagenase assays and detection limits of 15 mU of 
enzyme activity were reported (Lindblad and Fuller, 1982). 
Levels of Connective Tissue Degrading Enzymes in 
Normal Fibroblasts, DLD-1 Colon Carcinoma, and 
B16-F10 Melanoma Cells 
The levels of collagenolytic and elastolytic activity 
measured in these three cell lines are not easily compared 
to published values for other cell lines because of varia-
tions in the type of substrate used and the temperatures 
at which the assays were performed. Fibroblasts are one 
of the highest collagenase producers, collagenase protein 
represents 6% of the total protein exported by these cells 
(Valle and Bauer, 1979). DLD-1 colon carcinoma cells pro-
duc ed levels of collagen degrading activity that were com-
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parable to those produced by normal dermal fibroblasts. 
DLD-1 cells produced considerably more collagenolytic 
activity than highly metastatic B16-Fl0 murine melanoma 
cells. Bl6-F10 cells are a subline of the B16 melanoma 
parent line which have been selected in vivo and in vitro 
for their ability to form experimental metastases (Fidler, 
1973). 
The location of elastase activity appears to vary 
with different cell types (Werb et al, 1982). The elastin 
degrading activity produced by DLD-1 cells was found almost 
exclusively in the culture medium. Elastases from pan-
creatic cells and macrophages are also secreted into the 
growth medium (Barrett et al, 1980; Banda and Werb, 1981). 
Elastolytic activity has also been detected in the media of 
cultured human breast carcinoma cells (Kao et al, 1982). 
The elastin degrading activity produced by the normal fibro-
blasts and B16-F10 cells was found in both the cellular 
compartment and the media, with a greater portion being 
cell-associated. Hornebeck et al (1980) bas detected 
elastase activity in the Triton X-100 extracts of fibro-
blasts and smooth muscle cells. Neutrophil elastase is 
also known to be localized intracellularly (Werb et al, 
1982). 
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Characterization of DLD-1 Collagen Degrading Activities 
One of the objectives of this study was to analyze 
the collagen degrading activities produced by DLD-1 cells 
to determine if Type I and Type V collagen were degraded 
by the same or different enzymes. DEAE cellulose partially 
separated Type I and Type V collagen degrading activities. 
All of the Type I collagen degrading activity added to the 
column bound and eluted in two peaks. DLD-1 Type I colla-
gen degrading activity appears to be an anionic protein 
since it bound to the positively charged resin. The small 
peak of activity which eluted during the second gradient 
may be the same Type I collagenolytic activity complexed 
~ to a more strongly anionic media protein allowing a 
stronger interaction between the column and protein to 
occur. Protein-protein interactions involving colla-
genase and other culture media proteins has been docu-
mented (Fiedler-Nagy et al, 1976). Huang and Abramson 
(1975) and Woolley et al (1973) have characterized Type I 
collagenase from guinea pig and human skin cells as 
anionic proteins, the DLD-1 Type I collagenolytic activity 
appears to be similar to these enzymes. Several other 
Type I collagenases have been characterized and exhibit 
opposite charge properties. Rheumatoid synovial colla-
genase and rabbit v2 ascites tumor collagenase fail to 
bind to anionic resins (Woolley et al, 1975a, McCroskery 
et al, 1975). Type I collagenase from human skin fibro-
blasts appears to have the capacity to bind to both 
anionic and cationic resin under similar conditions 
(Stricklin et al, 1977; Woolley et al, 1973). 
The majority of the Type V collagen degrading 
activity in DLD-1 media did not bind to the DEAE column 
while a minor portion bound tightly. This protein 
appears to be cationic in nature. The minor fraction of 
the Type V collagenolytic activity which did bind to the 
column may be a complex of enzyme and another media pro-
tein which binds tightly to column. These results were 
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different from those obtained by Mainardi et al (1980a) 
who separated macrophage Type I and Type V collagenolytic 
activities. All the Type V collagen degrading activity 
from macrophages bound to DEAE cellulose. The difference 
in the physiochemical properties of these two Type V 
collagenolytic activities may simply reflect a difference 
in enzymes derived from macrophages and neoplastic 
epithelial cells. Although the majority of Type V 
collagenolytic activity from DLD-1 cells failed to bind 
to the column, DEAE cellulose chromatography was an effec-
tive method for partially separating Type I and Type V 
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collagen degrading activities. 
The two partially separated collagenase activities 
were further purified and characterized by gel filtration 
chromatography on Ultrogel AcA44. The Type V collagen 
degrading activity which did not bind to the DEAE column 
was fractionated into two peaks of enzymatic activity by 
gel filtration chromatography. The major peak of enzyme 
activity from the Ultrogel chromatogram eluted in the 
54,000 dalton M.W. range. A small peak of enzymatic 
activity was present in the V , indicating a M.W. of 
0 
200,000 daltons or greater. Large M.W. peaks of enzyme 
activity have been encountered during collagenase puri-
fications (Fidler-Nagy, 1977; Woolley et al, 1973; Huang 
and Abramson, 1975; Brikedal-Hansen et al, 1976). These 
peaks may be polymers of enzyme molecules or complexes of 
enzyme molecules and fragments of the collagen substrate 
(Woolley et al, 1973; Fidler-Nagy, 1977). Presently, only 
three Type V collagen degrading activities have been 
reported (Liotta et al, 1980; Mainardi et al, 1980a; Rich 
et al, 1983), and only one study has reported a M.W. 
Reticulium cell sarcoma Type V collagenolytic activity 
has a M.W. of 80,000 daltons (Liotta et al, 1980). The 
difference in M.W. between DLD-1 Type V collagen degrad-
ing activity and the reticulium cell sarcoma activity may 
represent a difference in the enzyme produced by two 
different cell types. Alternatively, the activity re-
ported by Liotta et al (1980) may be a complex of enzyme 
and a collagen degradation fragment. 
The major peak of Type I collagen degrading 
activity from the DEAE chromatogram was also fraction-
ated into two peaks of enzymatic activity by Ultrogel 
chromatography. One peak eluted in the V and may be a 
0 
complex of collagenase and collagen. Native collagens 
have M.S.'s of approximately 300,000 daltons and would 
elute from the Ultrogel column in the V • Collagenases 
0 
are known to bind tightly to their substrates (Stricklin 
et al, 1978). The second peak of activity eluted in the 
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60,000 dalton M.W. range. This M.W. is in agreement with 
M.W.'s reported for Type I collagenases isolated from two 
other carcinoma cell lines. A M.W. of 63,000 daltons was 
reported for a rat prostate carcinoma collagenase (Huang 
et al, 1979) and 68,000 daltons has been cited as the M.W. 
of Type I collagenase from a squamous cell carcinoma of 
the parotid gland (Huang et al, 1982). These minor dif-
ferences in M.W. may be due to the different types of gel 
filtration media used in each study. A third Type I 
collagenase isolated from an ascitic carcinoma cell line 
91 
has been characterized and a M.W. of 42,000 daltons was 
reported (Wolf and Wirl, 1982). The differences in M.W. 
between the ascites cell enzyme and the other Type I 
collagenases may be due to the presence of substrate 
fragments complexed with the enzyme or the same colla-
genases originating from different species or tissues may 
simply be heterogeneous. 
The third pool of collagen degrading activity gen-
erated by DEAE cellulose was fractionated into three peaks 
of activity by gel filtration chromatography. A high M.W. 
peak of activity was found in the V and contained both 
0 
Type I and Type V collagenolytic activities. As in the 
two previous gel filtration chromatograms this peak was 
probably an enzyme-substrate complex. A peak of Type V 
collagenolytic activity eluted at a volume corresponding 
to 80,000 daltons. Liotta et al (1980) has also reported 
80,000 daltons as the M.W. of a reticulium cell sarcoma 
Type V collagenolytic activity. The third peak of activity 
generated by Ultrogel chromatography had a M.W. of 35,000 
daltons and contained predominately Type I collagenolytic 
activity. This activity has a M.W. similar to Type I 
collagenase purified from rabbit v2 ascites tumor homo-
genates (McCroskery et al, 1975). 
......._ 
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Type I collagenase from cultured human skin fibro-
blasts has been extensively characterized and two species 
of enzyme of different M.W. (45,000 and 50,000 daltons) 
have been separated (Stricklin et al, 1977; Stricklin et 
al, · 1978). The two enzyme were immunologically similar as 
determined by immunodiffusion. They were also found to 
have similar amino acid compositions, cyanogen bromide 
peptide analysis revealed 9 peptides from each enzyme, 8 
of which were common to both activities. Trypsinization 
could not convert the higher M.W. enzyme into the smaller 
one, the two proteins were considered to be different 
species of the same enzyme. DLD-1 colon carcinoma cells 
may also synthesize two different Type I and Type V colla-
gen degrading activities. Since these activi t i e s are not 
highly purified it is possible that the large M.W. forms 
of each collagenase may be a complex of enzyme and sub-
strate fragment. The two types of chromatography used in 
this study were adequate methods for partially separating 
DLD-1 Type I and Type V collagenolytic activities and 
estimating their M.W. However, these methods were unable 
to completely separate the enzymes from a large M.W. pro-
tein, mostly likely their substrate. The complete separa-
tion of the enzymes from their substrates may require more 
extreme purification conditions. The addition of urea or 
Triton X-100 to the buffer systems or heating the enzyme 
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containing sample to 60°C prior to subsequent purifica-
tion steps have all been used to completely dissociate 
collagenases from their substrates (Harris and Vater, 
1982). 
Type I and Type V collagenolytic activities from 
DLD-1 cells were found to have similar inhibition pro-
files. The Type V collagen degrading activities reported 
by Mainardi et al (1980a) and Liotta et al (1980) were 
characterized as metalloproteinases and had no serine pro-
tease activity. The DLD-1 Type V collagen degrading 
activity can be similarly characterized since it was 
inhibited by EDTA but not PMSF. All Type I collagenases 
have been characterized as metalloproteinases and are 
uneffected by serine protease inhibitors (Harris and 
Vater, 1982). The DLD-1 Type I collagenolytic activity 
is predominately a metalloproteinase. A non-collagenase 
enzyme having serine protease activity may also be pre-
sent in the crude collagenase preparation. This activity 
could act on the substrate following the initial cleavage 
of the triple helix by the collagenolytic metalloprote-
inaseactivity. Collagenase from a rabbit v2 ascites cell 
carcinoma was inhibited by DTT (McCroskery et al, 1975) as 
were both Types I and V collagen degrading activities from 
DLD-1 cells. These enzymes may require intact disulfide 
bond for maximal activity since the reducing agent (DTT) 
diminished enzymatic activity. 
Effects of DMF on DLD-1 Colon Carcinoma Cells 
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The effects of DMF on the turmorigenicity, morphology 
and in vitro growth properties of DLD-1 colon carcinoma 
cells has been examined (Dexter et al, 1979; Dexter and 
Hager, 1980). In vitro DMF reduces the growth rate of 
DLD-1 cells and causes the cells to enlarge (Dexter et al, 
1979). DMF treated cells appear less round and more 
"leafy" than untreated cells. Concommitant with these 
morphological changes phase optic microscopy has revealed 
~that DMF treated cells have a higher cytoplasmic to nuclear 
ratio (Dexter et al, 1979). In this study cells treated 
with DMF contained more protein and RNA per cell and less 
DNA per cell than control cells. This finding is in agree-
ment with those obtained by phase optic microscopy. 
Treatement of DLD-1 cells with DMF resulted in the 
increased production of Type I and Type V collagenase and 
cell-associated elastase activities. It is unlikely that 
DMF had a selective effect stimulating the production of 
these particular proteases. The increases in enzymatic 
....... 
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activity probably resulted from a non-specific increase in 
the rate of protein synthesis. This hypothesis, however, 
cannot explain the decrease in media elastase activity seen 
in DMF treated cultures. This decrease was not statisti-
cally significant and the value may be erroneous since the 
corresponding standard deviation was very large. 
To determine if the effect of DMF on protease produc-
tion was the result of an increased rate of protein syn-
thesis, the rate of incorporation of 3H-glycine into pro-
tein was measured. After three hours of growth in label 
containing media, the DMF cultures appeared to be incor-
porating label slower than control cultures, although the 
decrease was significant only when the data were expressed 
per unit of DNA. After six hours of growth, the DMF 
cultures were synthesizing protein faster than controls. 
This increased rate of protein synthesis could explain the 
increased levels of Type I and Type V collagenases and 
cellular elastase activities present in DMF treated cul-
tures. The decreased rate of incorporation of 3H-glycine 
seen in DMF treated cells at the three hour point may not 
be a true indicator of decreased macromolecule synthesis, 
the decrease could have resulted from an initial lag in 
the rate of glycine penetration into the cells. DMF treat-
ment may have altered the cell membrane configuration 
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resulting in a decreased rate of amino acid uptake. After 
longer growth periods in label-containing media sufficient 
quantities of 3H-glycine may have entered the DMF treated 
cells and allowed their rate of protein synthesis to exceed 
controls. 
If the DMF effect on enzyme production was due to 
increased enzyme biosynthesis, blockade of protein syn-
thesis with cycloheximide should inhibit the effect. Con-
trol and DMF treated cultures were treated with 1 µg cyclo-
heximide/ml, a dose which inhibited collagenase production 
by endotoxin-activated macrophages (Wahl et al, 1974). The 
effect of DMF on Type I and Type V collagenolytic activ-
~i ties was still apparent however, in the presence of cyclo-
heximide. This result indicated that DMF could produce 
its effect independent of protein synthesis. It has been 
reported that collagenases are synthesized and stored 
intracellularly as zymogens (Harper et al, 1971). The DMF 
treated cells may have synthesized and stored intracellu-
larly greater quantities of these enzymes prior to the 
inhibition of protein synthesis. The increased levels of 
these enzymes seen in DMF treated cells treated with cyclo-
heximide could have been the result of the release of 
greater quantities of stored enzyme. 
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When DMF treated cells were exposed to cycloheximide 
for 24 hours, the cells secreted large amounts of elastase 
into the media. Control cells did not respond to cyclo-
heximide in the same manner. There was no significant 
difference in media elastase levels in control and control 
cells treated with cycloheximide, this was analogous to the 
effects on collagenolytic activities. The elastase 
activity secreated by DMF treated cells following cyclo-
heximide treatement most likely originated from a pre-
existing intracellular store of enzyme. Cycloheximide 
has been shown to effect the turnover of tyrosine trans-
aminase in cultured liver cells leading to increased 
levels of transaminase activity (Kenney, 1967; Hershko and 
Tomkins, 1971). It was postulated that the s ynthesis of 
proteases responsible for the degradation of intracellular 
proteins are more sensitive to cycloheximide treatment than 
the synthesis of tyrosine transaminase (Kenney , 1967). 
DLD-1 elastase levels may have been increased due to 
decreased intracellular degradation of the enzyme. 
CONCLUSIONS 
1. Type V collagen was purified from human amnions, 
labeled and used as a substrate in an improved 
assay for measuring Type V collagen degrading 
activity. Non-degraded substrate molecules were 
separated from degraded substrate fragments by 
precipitation with 23% dioxane/methanol. 
2. DLD-1 colon carcinoma cells, B16-Fl0 murine 
melanoma cells, and normal dermal fibroblasts 
produced proteases which could degrade Type I 
and Type V collagen and elastin. 
3. Type I and Type V collagen degrading activities 
secreted by DLD-1 cells were characterized as 
metalloproteinases. These activities were 
partially separated using DEAE cellulose chroma-
tography. 
4. Two forms of DLD-1 Type I collagenolytic activity 
were partially purified and had molecular weights 
of 60,000 and 35,000 daltons. 
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5. Two forms of DLD-1 Type V collagenolytic activity 
were partially purified and had molecular weights 
of 80,000 and 54,000 daltons. 
6. DMF treatment increased the production of Type I 
and Type V collagenolytic activities and cell-
associated elastinolytic activity by DLD-1 cells. 
7. DMF treatment increased the cellular protein and 
RNA content and decreased the DNA content of DLD-1 
cells. 
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